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Overview 
A recycling endosome (RE) is an organelle that functions as a sorting station of 
endocytic cargoes to their appropriate destinations.  The endosomal sorting machinery 
is essential for fundamental cellular functions that underlie developmental processes.  
However, the precise molecular mechanisms that regulate the biogenesis and functions 
of REs are poorly understood.  To elucidate the molecular bases of regulation and 
functions of REs, I focused on the small GTPase Rab, a conserved switch molecule for 
membrane trafficking by cycling between a GDP-bound inactive state and a GTP-bound 
active state.  The active Rab drives a variety of membrane trafficking steps such as 
vesicle budding, transport, and fusion by recruiting its specific effector protein.  Rab 
family consists of ~60 members in mammalian cells, and each Rab member is thought 
to regulate different intracellular membrane trafficking pathways.  In this thesis, I 
report two mechanisms involving the regulation of REs: “The Rab35–centaurin-β2 
complex regulates neurite outgrowth (Chapter 1)” and “Rab10 regulates tubular 
endosome formation through KIF13A/B motors (Chapter 2)”. 
In Chapter 1, I performed the functional analysis of Rab35 that acts as a regulator 
of REs during neurite outgrowth.  Previous studies from our groups have shown that 
Rab35 regulates neurite outgrowth by recruiting several Rab35-effectors to REs.  
Since Rab35 was unable to bind to all Rab35-effectors simultaneously, it is reasonable 
to expect that Rab35 uses them as the situation demands.  However, little is known 
about the mechanism by which Rab35 recognizes each Rab35-effector and contribution 
of each effector to neurite outgrowth.  In this chapter, I focused on centaurin-β2 (also 
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called ACAP2) and attempted to identify the critical residues for the specific interaction 
between Rab35 and centaurin-β2 by mutation analyses.  I found that two Thr residues 
in the switch II region of Rab35 are responsible for the binding of centaurin-β2, but not 
all other Rab35-effectors.  Furthermore, knockdown-rescue experiments showed that a 
centaurin-β2-binding-deficient Rab35 mutant, Rab35(T76S/T81A), failed to support 
NGF-induced neurite outgrowth, indicating that Rab35–centaurin-β2 complex is 
necessary for neurite outgrowth. 
In Chapter 2, I focused on the tubular endosome, which has recently been 
discovered as a novel RE distinct from a well-known transferrin receptor-positive RE.  
Although the tubular endosome has been characterized as a RE involving a 
clathrin-independent endocytic pathway, the molecular mechanism of the tubular 
endosome formation remains largely unknown.  In the second chapter, I tried to 
identify essential Rabs for the tubular endosome formation and to uncover their role in 
tubular endosomes.  First, I performed a comprehensive localization screening of the 
Rab subfamily and succeeded in identifying Rab10 as a novel protein predominantly 
localized at tubular endosomes.  I also found that knockout of Rab10 completely 
disrupted the formation of tubular endosomes.  Furthermore, I identified kinesin 
motors KIF13A/B as novel Rab10-interacting proteins by means of in silico screening 
and found that their knockout also disrupted tubular endosome formation.  The results 
demonstrated that both the Rab10-binding homology domain and the motor domain of 
KIF13A are required for Rab10-positive tubular endosome formation.
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Abbreviations 
 
GAP: GTPase-activating protein 
AA: amino acids 
ACAP: ArfGAP with coiled-coil, ankyrin repeat and PH domain 
ANKR: ankyrin repeat 
Centβ2: centaurin-β2 
CIE: clathrin-independent endocytosis 
CME: clathrin-mediated endocytosis 
DKO: double knockout 
EE: early endosome 
EGFP: enhanced green fluorescent protein 
HRP: horseradish peroxidase 
KO: knockout 
mStr: monomeric Strawberry 
NGF: nerve growth factor 
PCC: Pearson’s correlation coefficient 
QL: Q67L 
Rab35BP: Rab35-binding protein 
RBD10: Rab10-binding domain 
RBD35: Rab35-binding site 
RE: recycling endosome 
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RHD10: Rab10-binding homology domain 
shRNA: short hairpin RNA 
siRNA: small interfering RNA 
SN: S22N 
SR: shRNA/siRNA-resistant 
Tf: transferrin 
TfR: transferrin receptor 
trans-Golgi network: TGN 
WT: wild-type 
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Chapter 1 
 
Rab35–centaurin-β2 complex regulates neurite outgrowth 
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Abstract 
 
 The small GTPase Rab35 is a molecular switch for membrane trafficking that 
regulates a variety of cellular events.  It has previously shown that Rab35 promotes 
neurite outgrowth of nerve growth factor-stimulated PC12 cells through interaction with 
centaurin-β2 (also called ACAP2).  Centaurin-β2 is the only Rab35-binding protein 
reported thus far that exclusively recognizes Rab35 and does not recognize any of the 
other 59 Rabs identified in mammals, but the molecular basis for the exclusive 
specificity of centaurin-β2 for Rab35 has remained completely unknown.  In this 
thesis, I performed deletion and mutation analyses and succeeded in identifying the 
residues of Rab35 and centaurin-β2 that are crucial for formation of a 
Rab35–centaurin-β2 complex.  I found that two threonine residues (Thr-76 and 
Thr-81) in the switch II region of Rab35 are responsible for binding centaurin-β2 and 
that the same residues are dispensable for Rab35 recognition by other Rab35-binding 
proteins.  I also determined the minimal Rab35-binding site (RBD35) of centaurin-β2 
and identified two Asn residues (Asn-610 and Asn-691) in the RBD35 as key residues 
for its specific Rab35 recognition.  I further showed by knockdown-rescue approaches 
that neither a centaurin-β2-binding-deficient Rab35(T76S/T81A) mutant  nor a 
Rab35-binding-deficient centaurin-β2(N610A/N691A) mutant supported neurite 
outgrowth of PC12 cells, thereby demonstrating the functional significance of the 
Rab35–centaurin-β2 interaction during neurite outgrowth of PC12 cells. 
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Introduction 
 
 The Rab family is the largest family within the Ras superfamily of small GTPases 
and is conserved in all eukaryotes.  The members of the Rab family are generally 
thought to be key players in membrane trafficking, which underlies a variety of cellular 
events (1–4).  Rabs act as switch molecules that cycle between two nucleotide-bound 
states, a GTP-bound active state and a GDP-bound inactive state, and the cycling is 
controlled by two regulatory factors, a guanine nucleotide exchange factor (GEF), 
which activates Rabs, and a GTPase-activating protein (GAP), which inactivates Rabs 
(5, 6).  The active Rabs drive various steps of membrane trafficking, including vesicle 
budding from donor membranes, vesicle movement along the cytoskeleton, vesicle 
docking to acceptor membranes, and vesicle fusion, by recruiting their specific effector 
molecules (1–4). 
 The results of recent comprehensive screenings for mammalian Rab effectors 
have indicated that interactions between Rabs and their effectors are more complicated 
than previously thought (7, 8), and most Rab isoforms appear to interact with two or 
more different types of effector molecules.  Because mammalian cells and tissues are 
highly specialized, the presence of multiple Rab effectors may enable a single Rab 
isoform to control different types (or steps) of membrane trafficking in specialized cells.  
However, the physiological significance of the presence of multiple Rab effectors and 
their Rab recognition mechanisms are poorly understood. 
 Rab35 is one such Rab protein and has been shown to bind various candidate 
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effector molecules, including MICAL-1 (7), MICAL-L1 (7, 9, 10), MICAL-cl (7), 
OCRL (7, 11), RUSC2 (12), Fascin1 (13), and centaurin-β2 (8, 14), and to be involved 
in various cellular events, including cytokinesis (11, 15, 16), cell migration (17, 18), 
phagocytosis (19, 20), immunological synapse formation (21), myelination (22), and 
neurite outgrowth (10, 14, 23, 24), most likely through regulation of endocytic recycling 
(or REs) (25).  The pleiotropic roles of Rab35 in membrane trafficking may be 
attributable to the presence of multiple Rab35 effectors, but the involvement of 
individual Rab35 effectors in the above cellular events has remained largely unknown.  
Moreover, almost nothing is known about the structural basis of Rab35–effector 
complexes, e.g., about the critical amino acid residues for the Rab35–effector 
interactions.  Although identification of a specific amino acid(s) in Rab35 that is 
exclusively involved in interaction with only one effector molecule would enhance our 
understanding of the molecular mechanism of Rab35-mediated membrane trafficking, 
no attempts have ever been made to biochemically analyze Rab35–effector interactions. 
 In this thesis, I focused on centaurin-β2 (also called ACAP2, ArfGAP with 
coiled-coil, ankyrin repeat and PH domain), an Arf6-GAP (26) that is required for nerve 
growth factor (NGF)-induced neurite outgrowth of PC12 cells (8, 14), and analyzed the 
exclusive specificity of the Rab35–centaurin-β2 interaction with Rab35 by performing 
deletion and mutation analyses.  The results showed that two Thr residues (Thr-76 and 
Thr-81) in the switch II region of Rab35 are responsible for binding centaurin-β2 and 
that they are not responsible for Rab35 binding to other effectors.  Knockdown-rescue 
experiments showed that a centaurin-β2-binding-deficient Rab35 mutant, 
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Rab35(T76S/T81A), did not support NGF-induced neurite outgrowth.  Based on my 
findings, I discuss the utility of the Rab35(T76S/T81A) mutant as a tool to investigate 
the involvement of the Rab35–centaurin-β2 complex in Rab35-dependent cellular 
events. 
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Materials and Methods 
 
Antibodies 
 Horseradish peroxidase (HRP)-conjugated anti-FLAG tag (M2) mouse 
monoclonal antibody, anti-FLAG tag antibody-conjugated agarose (Sigma-Aldrich), 
HRP-conjugated anti-T7 tag mouse monoclonal antibody (Merck Biosciences Novagen, 
Darmstadt, Germany), anti-centaurin-β2 goat polyclonal antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA), anti-GFP rabbit polyclonal antibody (MBL, Nagoya, 
Japan), and anti-β-actin mouse monoclonal antibody (Applied Biological Materials, 
Richmond, BC, Canada) were obtained commercially.  The anti-Rab35 antibody was 
prepared as described previously (14). 
 
Plasmid Construction 
 Mutant mouse Rab35 expression plasmids carrying a Thr-to-Ser and Thr-to-Ala 
double mutation at amino acid positions 76 and 81, respectively, named 
Rab35(T76S/T81A), a swapping mutation in the switch II region between Rab35 
(amino acids (AA) 82–88) and Rab5A (AA70–76), named Rab35(S5A), see Figure 2A 
for details, or a small interfering RNA (siRNA)-resistant mutant, named Rab35SR, were 
produced by PCR sewing methods essentially as described previously (27).  In brief, 
PCRs were performed to generate two DNA fragments having overlapping ends into 
which specific alterations were introduced by using two sets of oligonucleotides, e.g., 
5’-CGGATCCATGGCCCGGGACTACGACCA-3’ (Rab35-Met primer, sense) and 
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5’-ATGGGCCCCCCGATAATAGGAAGA-3’ (Rab35-T76S/T81A-3’ primer, 
antisense); and 5’-TCTTCCTATTATCGGGGGGCCCAT-3’ (Rab35-T76S/T81A-5’ 
primer, sense) and 5’-TTAGCAGCAGCTTTCTTTCG-3’ (Rab35-stop primer, 
antisense) (substituted nucleotides are underlined, and stop codons are in bold).  After 
purification of the two DNA fragments, they were combined to generate the fusion 
product by a second PCR, in which the Rab35-Met primer and Rab35-stop primer were 
used.  The resulting Rab35 mutant cDNAs were subcloned into the pEGFP (enhanced 
green fluorescent protein)-C1 vector (Clontech-Takara Bio Inc., Shiga, Japan), 
pGBD-C1 vector (28), and pEF-FLAG tag expression vector (29).  Mutant mouse 
centaurin-β2 fragments carrying a N610A, N632A, T648A, N691A, T695A/E697A, 
N724A, S730A, L733A/Y734A, Q764A/Q765A, N610A/N691A, or T648A/N691A 
mutation(s) were similarly produced by the method described above, and they were 
subcloned into the pEGFP-C1 vector, pAct2 vector (Clontech-Takara Bio Inc.), and/or 
pEF-T7 tag expression vector (29).  Deletion mutants of centaurin-β2 (AA580–770, 
AA630–770, AA662–770, AA580–755, AA580–745, AA580–730, AA580–697, and 
AA630–730; see Figure 5A for details) were prepared by conventional PCR techniques 
as described previously (30).  cDNAs encoding the ankyrin repeat (ANKR) domain of 
centaurin-β1 (Centβ1-ANKR, AA548–740) and of centaurin-β5 (Centβ5-ANKR, 
AA565–833), and full-length of Fascin1 were amplified by conventional PCR 
techniques as described previously (29) and were then subcloned into the pAct2 vector 
and/or pEF-T7 tag expression vector.  Deletion mutants of centaurin-β2 
(pAct2-Centβ2-ANKR and pEGFP-C1-Centβ2SR(ΔANKR)) were prepared as described 
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previously (8, 14).  Short hairpin RNAs (shRNAs) targeting rat Centβ2 (shCentβ2, 
19-base target site: 5’-GGGTATCTGTTCAAACGAG-3’) and rat Rab35 (shRab35 #1, 
19-base target site: 5’-TATTAGTGGGCAATAAGAA-3’) were also prepared as 
described previously (14).   
 
Co-immunoprecipitation Assays in COS-7 Cells and Immunoblotting 
 T7-tagged centaurin-β2 (centaurin-β1/2/5-ANKR or Fascin1) and FLAG-tagged 
Rab35 (wild-type (WT), T76S/T81A, or S5A) were transiently expressed in COS-7 
cells, and their associations were evaluated by co-immunoprecipitation assays with 
anti-FLAG tag antibody-conjugated agarose beads as described previously (29, 31).  
Proteins bound to the beads were analyzed by 10%, or 12.5% SDS-PAGE followed by 
immunoblotting with HRP-conjugated anti-T7 tag antibody (1:10,000 dilution) and 
HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution).  Immunoreactive bands 
were visualized by enhanced chemiluminescence (GE Healthcare Ltd.).  The blots 
shown in this thesis are representative of at least three independent experiments. 
 
Yeast Two-hybrid Assays 
 Yeast two-hybrid assays were performed by using pGBD-C1-Rab35(Q67L, 
Q67L/T76S/T81A, or Q67L/S5A) lacking the C-terminal geranylgeranylation site and 
pGAD-C1-RUSC2-RUN (12), pAct2-MICAL-1, pAct2-MICAL-cl, pAct2-MICAL-L1, 
pAct2-OCRL (7), pAct2-Fascin1, or pAct2-Centβ2-ANKR (8), or by using 
pGBD-C1-Rab35(Q67L or S22N)ΔCys (hereafter simply designated as QL or SN) and 
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pAct2-Centβ2-ANKR(WT or its mutants), pAct2-Centβ1-ANKR, or 
pAct2-Centβ5-ANKR as described previously (7, 8, 32).  The yeast strain, medium, 
culture conditions, and transformation protocol used were as described previously (28).  
The assays were performed in duplicates and the results of one representative set of 
assays are shown. 
 
Cell Cultures and Transfections 
 PC12 cell and COS-7 cell cultures and plasmid transfections were performed 
essentially as described previously (14).  Plasmids were transfected into cultured cells 
1 day after plating, by using Lipofectamine LTX or Lipofectamine 2000 (Invitrogen), 
each according to the manufacturer’s instructions.  Because the protein expression 
level of wild-type and mutant Rab35SR (or centaurin-β2SR) differs slightly even when 
the same amount of plasmid is transfected into PC12 cells, the amounts of plasmid used 
for transfection were varied (e.g., 0.04–0.1 µg of the pEGFP-C1-Rab35SR plasmid and 
0–0.06 µg of the pEGFP-C1 empty vector was added to keep the total amount of 
plasmid constant) to maintain the amount of recombinant proteins at the same level 
(Figures 3C and 7C).  To avoid overexpression in the knockdown-rescue experiments, 
I tried to maintain the level of the recombinant proteins at levels that were similar to the 
level of the endogenous protein (Figures 3C and 7C).  Under my experimental 
conditions, the transfection efficiency of the EGFP-expressing plasmids into PC12 cells 
was approximately 40–50%. 
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Immunofluorescence Analysis 
 All of the procedures used to perform the immunofluorescence analyses have 
been described previously (14). 
 
Neurite Outgrowth Assays 
 Neurite outgrowth assays were performed essentially as described previously (14).  
In brief, PC12 cells that had been transfected with pSilencer plasmids together with 
EGFP-tagged protein-expressing plasmids were treated with 100 ng/ml β-NGF (Merck 
Biosciences) for 36 h.  The transfected cells were identified by EGFP fluorescence and 
images of the cells were captured at random with a confocal fluorescence microscope 
(Fluoview FV1000; Olympus, Tokyo, Japan).  The total neurite length of each cell (see 
the broken lines in Figures. 3A and 7A) was measured with MetaMorph software 
(Molecular Devices, Sunnyvale, CA).  The results of the neurite outgrowth assays in 
this thesis are reported as means and SEM of data from three independent experiments 
(n = 100 cells; more than 30 cells were analyzed in each experiment).  Because the 
response of PC12 cells to NGF often differs according to the number of cell passages 
and the lot of NGF, I used PC12 cells with a similar passage number and NGF from the 
same lot in any one set of experiments. 
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Results 
 
Identification of Critical Residues in Rab35 for Specific Centaurin-β2 Binding by 
Site-directed Mutagenesis 
 Seven Rab35-binding proteins (Rab35BPs) have been identified thus far (7–13), 
but their Rab binding specificity is highly diversified, ranging from the exclusive Rab35 
binding activity of centaurin-β2 (Figure 1C) to the multiple-Rab binding activity of 
MICAL family proteins, all of which commonly interact with Rab8A/B, Rab10, Rab13, 
Rab15, and Rab35, and to the even broader Rab binding activity of OCRL, which 
interacts with 16 Rabs (summarized in Figure 1B).  In an attempt to identify the 
structural determinant responsible for the exclusive Rab35 binding specificity of 
centaurin-β2, I first focused on the switch II region of Rabs, which interact with most of 
the Rab35BPs (Figure 1A), because several amino acids in the switch II region of 
certain Rabs have previously been shown to be responsible for specific effector binding 
(32–38).  Since Rab1A/B, Rab8A/B, Rab10, Rab13, Rab15, and Rab35 are 
phylogenetically similar and belong to the same large branch in the phylogenetic tree 
(39), the amino acid sequences of their switch II region are highly conserved.  Careful 
inspection of their sequences, however, revealed two Thr residues, one at AA position 
76 (Thr-76) and the other at AA position 81 (Thr-81), that are unique to Rab35 
(arrowheads in Figure 1A).  To determine whether these two Thr residues are involved 
in the specific recognition of Rab35 by centaurin-β2, I performed site-directed 
mutagenesis and generated a Rab35(T76S/T81A) mutant that carries a switch II region 
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of Rab1A/B (arrowheads in Figure 1A).  Intriguingly, the results of the yeast-two 
hybrid assays showed that the T76S/T81A mutation impaired centaurin-β2 binding 
activity (Figure 1D, bottom panel), but had no effect on binding activity toward 
MICAL-1, MICAL-cl, MICAL-L1, OCRL, or RUSC2 (Figure 1D, top five panels).  
By contrast, I was unable to evaluate the effect of the T76S/T81A mutation on Fascin1 
binding by yeast two-hybrid assays, because even the wild-type Rab35 did not interact 
with Fascin1 at all under my yeast two-hybrid assay conditions (Figure 1D, second 
panel from the bottom).  To overcome this problem, I performed 
co-immunoprecipitation assays in COS-7 cells, and the results showed that both 
Rab35(WT) protein and Rab35(T76S/T81A) protein did in fact interact with Fascin1 
(Figure 1E).  I also investigated the impaired interaction between Rab35(T76S/T81A) 
and centaurin-β2 by performing co-immunoprecipitation assays in COS-7 cells.  As 
shown in Figure 1F, the T76S/T81A mutation dramatically decreased the binding 
activity toward centaurin-β2, although, in contrast to the results of the yeast two-hybrid 
assays (Figure 1D), residual binding activity still persisted.  These results indicated 
that both Thr-76 and Thr-81 in the switch II region of Rab35 are critical for recognition 
by centaurin-β2 but that they are not required for binding to other Rab35BPs. 
 
Contribution of the Switch II Sequence in Rab35 to Binding Activity toward 
Rab35BPs 
 Next, to evaluate the contribution of the entire switch II region of Rab35 to 
binding activity toward Rab35BPs I produced a switch II-swapping mutant of Rab35, 
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named Rab35(S5A), in which the switch II region of Rab35 was replaced by the switch 
II region of Rab5A, a Rab that is evolutionarily distant from Rab35 (39).  The results 
of the yeast two-hybrid assays showed that the Rab35(S5A) mutant exhibited no 
binding activity toward centaurin-β2 and exhibited decreased binding activity toward 
MICAL family members and OCRL, whereas the swapping mutation had no effect on 
RUSC2 binding activity (Figure 2B).  To further compare the centaurin-β2 binding 
ability of Rab35(T76S/T81A) and Rab35(S5A), I then performed 
co-immunoprecipitation assays in COS-7 cells.  As shown in Figure 2C, Rab35(S5A) 
hardly interacted with centaurin-β2 at all, in contrast to the reduced centaurin-β2 
binding activity of Rab35(T76S/T81A), suggesting that centaurin-β2 recognizes certain 
amino acid(s) in the switch II region of Rab35 besides Thr-76 and Thr-81. 
 
Effect of the T76S/T81A Mutation of Rab35 on NGF-induced Neurite Outgrowth of 
PC12 cells 
 Because the T76S/T81A mutation of Rab35 specifically caused a reduction in the 
centaurin-β2 binding activity without affecting binding activity toward other Rab35BPs 
(Figure 1D–E), the Rab35(T76S/T81A) mutant is expected to be a useful tool for 
evaluating the physiological significance of the interaction between Rab35 and 
centaurin-β2 by knockdown-rescue approaches.  To apply the Rab35(T76S/T81A) 
mutant as a tool to evaluate the physiological significance of the Rab35–centaurin-β2 
interaction, I focused on NGF-induced neurite outgrowth of PC12 cells, because we 
previously found that Rab35 recruits centaurin-β2 to Arf6-positive recycling endosomes 
20 
in PC12 cells and that knockdown of either of them with specific shRNAs inhibits 
neurite outgrowth (14) (Figure 3A, upper panels, and 3B).  When I re-expressed an 
shRNA-resistant form of Rab35(WT) (named Rab35SR(WT)) in Rab35-knockdown 
cells, NGF-induced neurite outgrowth was almost completely restored (Figure 3A, 
bottom left panel, and 3B), whereas re-expression of Rab35SR(T76S/T81A) in 
Rab35-knockdown cells failed to rescue the phenotype (Figure 3A, bottom middle panel, 
and 3B), indicating that the specific interaction between Rab35 and centaurin-β2 is 
crucial for neurite outgrowth.  Similarly, no rescue effect was observed with 
Rab35SR(S5A) (Figure 3A, bottom right panel, and 3B), which also lacks centaurin-β2 
binding activity (Figure 2B and 2C).  The lack of a rescue effect by these two mutants 
is unlikely to be attributable to their lower protein expression level, because equivalent 
amount of Rab35SR proteins were expressed under my experimental conditions (Figure 
3C).  Although the difference was not statistically significant, the 
Rab35SR(T76S/T81A)-re-expressing cells tended to possess slightly longer neurites 
than the Rab35SR(S5A)-re-expressing cells.  This difference may be explained by the 
residual centaurin-β2 binding activity of Rab35(T76S/T81A) as opposed to the almost 
completely absent centaurin-β2 binding activity of Rab35(S5A) (Figure 2C), or 
Rab35(T76S/T81A) may weakly promote neurite outgrowth through interaction with 
other Rab35BPs, e.g., MICAL-L1 (10). 
 
Rab35 Binding Activity of Centaurin-β1/ACAP1 and Centaurin-β5/ACAP3 
 In the next set of experiments, I turned my attention to centaurin-β2 and attempted 
21 
to identify the residues that are crucial for Rab35 binding activity.  Although we 
previously showed that a C-terminal ANKR domain of centaurin-β2 functions as a 
Rab35 effector domain (8, 14), nothing was known about its Rab35 recognition 
mechanism.  To identify the critical residues in the ANKR domain of centaurin-β2 that 
are responsible for Rab35 binding, I first compared the ANKR domain of ORP1L (i.e., 
Rab7-binding site) (40) and ANKR domain of VARP (i.e., Rab32/38-binding site) (32, 
41) with the centaurin-β2 ANKR domain.  Because of their low sequence conservation, 
however, I was unable to identify shared key residues that are responsible for Rab 
binding by these three ANKR domains.  I then turned my attention to Arf-GAPs, 
because approximately two thirds of mammalian Arf-GAPs contain ANKR domains, 
and because two of them (42, 43), centaurin-β1 (also called ACAP1) and centaurin-β5 
(also called ACAP3), contain a C-terminal ANKR domain similar to the centaurin-β2 
ANKR domain (Figure 4A).  If the ANKR domain of centaurin-β1/β5 also serves as a 
Rab35-binding site, comparison of their sequence was expected to be helpful in 
identifying key residues responsible for Rab35 binding.  To determine whether 
centaurin-β1 and centaurin-β5 are binding partners of Rab35, I cloned the cDNAs of the 
mouse ANKR domains of centaurin-β1/β5 (Figure 4A) and subjected them to yeast 
two-hybrid assays as described above (Figure 4B).  To my surprise, however, neither 
the ANKR domain of centaurin-β1 nor the ANKR domain of centaurin-β5 interacted 
with Rab35, despite their relatively high sequence similarity to the ANKR domain of 
centaurin-β2, which recognizes a GTP-locked (Q67L = QL) form of Rab35, but not its 
GDP-locked (S22N = SN) form.  I confirmed the lack of interaction between Rab35 
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and centaurin-β1/β5 by performing co-immunoprecipitation assays in COS-7 cells 
(Figure 4C).  These results suggested that amino acid residues in the centaurin-β2 
ANKR domain that are not conserved in centaurin-β1 or centaurin-β5 were good 
candidates for key residues responsible for Rab35 binding.  Because the original 
centaurin-β2-ANKR construct contains another regions besides the ANKR domain 
(Figure 4A), I wanted to reduce the Rab35-binding region to a minimum before 
searching for the candidate residues by sequence comparisons between the C-terminal 
domains of centaurin-β1, -β2, and -β5. 
 
Determination of the Minimal Rab35-binding Site in Centaurin-β2 
 To determine the minimal Rab35-binding site (named RBD35), I generated a 
series of deletion mutants (summarized in Figure 5A) and evaluated their Rab35 
binding activity by yeast two-hybrid assays.  The results showed that only the 
AA580–755 construct strongly interacted with Rab35(QL), the same as the original 
ANKR construct (AA580–770) did (Figure 5B),  whereas the other deletion constructs 
did not interact or hardly interacted with Rab35(QL).  Similar results were obtained by 
co-immunoprecipitation assays in COS-7 cells: deletion of C-terminal 15 amino acids 
from the original ANKR construct (i.e., AA580–755) had no effect on Rab35 binding 
activity, whereas deletion of C-terminal 30 amino acids (i.e., AA580–745) impaired 
Rab35 binding activity (Figure 5C).  I therefore concluded that the minimal RBD35 in 
centaurin-β2 is AA580-755 and that additional amino acids in the C-terminal flanking 
region of the ANKR domain, i.e., AA730-755, are required for high-affinity Rab35 
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binding. 
 
Identification of Critical Residues in the ANKR Domain of Centaurin-β2 That 
Specifically Recognize Rab35 by Site-directed Mutagenesis 
 Based on the results shown in Figure 5B, I searched for candidate residues 
responsible for Rab35 binding in the minimal RBD35 of centaurin-β2 by performing 
sequence comparisons between centaurin-β1, -β2, and -β5 (Figure 6A).  The 12 
candidate residues conserved in centaurin-β2 alone, i.e., Asn-610, Asn-632, Thr-648, 
Asn-691, Thr-695, Glu-697, Asn-724, Ser-730, Leu-733, Tyr-734, Gln-764, and 
Gln-765, were selected, and each was replaced with Ala by site-directed mutagenesis 
(arrowheads in Figure 6A).  The results of the yeast two-hybrid assays showed that 
none of the single point mutations dramatically decreased binding activity toward 
Rab35(QL) (Figure 6B).  However, since the yeast cells expressing the N610A, 
T648A, or N691A mutant appeared to grow slowly, I generated double mutants of 
centaurin-β2, i.e., N610A/N691A and T648A/N691A, and assessed their Rab35 binding 
activity by yeast two-hybrid assays.  As shown in Figure 6C, the N610A/N691A 
double mutant abrogated binding activity toward Rab35(QL), whereas the 
T648A/N691A double mutant still exhibited significant Rab35 binding activity.  
Similar results were obtained by co-immunoprecipitation assays in COS-7 cells, that is, 
the Rab35 binding activity of centaurin-β2(N610A/N691A) mutant was dramatically 
reduced (lane 2 in the middle panel of Figure 6D).  These results indicated that both 
Asn-610 and Asn-691 in the ANKR domain of centaurin-β2 are critical for recognition 
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by Rab35, and I decided to use the N610A/N691A mutant as a Rab35-binding-deficient 
mutant in the subsequent analysis. 
 
Effect of the N610A/N691A Mutation of Centaurin-β2 on NGF-induced Neurite 
Outgrowth of PC12 cells 
 To investigate whether the centaurin-β2(N610A/N691A) mutant is capable of 
supporting NGF-induced neurite outgrowth, I performed knockdown-rescue 
experiments as described previously (14).  Consistent with our previous finding, 
knockdown of centaurin-β2 with specific shRNA inhibited neurite outgrowth (Figure 
7A, upper panels, and 7B), whereas re-expression of centaurin-β2SR(WT) in 
centaurin-β2-knockdown cells rescued the phenotype (14) (Figure 7A, bottom left panel, 
and 7B).  By contrast, re-expression of centaurin-β2SR(N610A/N691A) in 
centaurin-β2-knockdown cells failed to rescue the phenotype (Figure 7A, bottom 
middle panel, and 7B), the same as the centaurin-β2SR(ΔANKR) mutant, which 
completely lacked the RBD35 (14) (Figure 7A, bottom right panel, and 7B).  The lack 
of a rescue effect by these two mutants is unlikely to be attributable to their lower 
protein expression level, because equivalent amounts of centaurin-β2SR proteins were 
expressed in the centaurin-β2-knockdown cells (Figure 7C).  These results taken 
together indicated that the Rab35–centaurin-β2 interaction is essential for neurite 
outgrowth. 
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Discussion 
 
 We and others have previously identified a variety of Rab35BPs (7–13), each of 
which showed extremely different Rab binding specificity (Figure 1B).  Only one of 
them, centaurin-β2, had been shown to specifically recognize Rab35 (Figure 1C) (8), 
but the molecular determinant(s) responsible for the exclusive Rab35 binding specificity 
of centaurin-β2 had never been investigated.  In the present thesis, I performed 
site-directed mutagenesis and identified residues in Rab35, i.e., Thr-76 and Thr-81 in 
the switch II region, and in centaurin-β2, i.e., Asn-610 and Asn-691 in the ANKR 
domain, that are crucial for the formation of the Rab35–centaurin-β2 complex (Figures 
1 and 6).  Because Rab35 is the only Rab isoform that has a Thr residue at each of 
these positions in the switch II region (Figure 1A), centaurin-β2 is likely to specifically 
recognize these two Thr residues.  Actually, mutation of these Thr residues resulted in 
a dramatic reduction in the centaurin-β2 binding ability without affecting binding 
activity toward any of the other Rab35BPs (Figure 1D–F).  However, these results do 
not mean that other Rab35BPs besides centaurin-β2 recognize the switch II region of 
Rab35.  A switch II-swapping analysis indicated that the switch II region of Rab35 
also contributes to its recognition by most of the Rab35BPs (Figure 2).  Because 
RUSC2 normally bound to the Rab35(S5A) mutant, it must recognize some other 
region of Rab35 besides the switch II region, suggesting that Rab35 interacts with both 
RUSC2 and one of the other Rab35BPs.  Further work will be necessary to determine 
whether Rab35 actually interacts with more than one Rab35BP at the same time. 
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 Identification of the minimal Rab35-binding site (RBD35) in centaurin-β2 
provided other important information.  I previously thought that the ANKR domain of 
centaurin-β2 was necessary and sufficient for Rab35 binding activity, the same as the 
ANKR1 domain of Varp alone recognizes Rab32/38 (32), but the results of my deletion 
analysis indicated that an N-terminal flanking region and C-terminal flanking region 
(AA580–630 and AA730–755, respectively) of the ANKR domain are also required for 
high-affinity Rab35 binding activity (Figure 5).  This observation may well explain 
why other Arf-GAPs, e.g., centaurin-β1/5, which often have an ANKR domain (42, 43), 
do not interact with Rab35, because the N-terminal and C-terminal flanking regions of 
the ANKR domain are not well conserved among Arf-GAPs.  A more detailed 
structural analysis will be needed to evaluate the contribution of the N/C-terminal 
flanking regions of the ANKR domain to Rab35 binding. 
 The fact that more than one Rab35BP is simultaneously expressed in a single cell 
type (10, 14) makes it difficult to determine which Rab35 effector is involved in 
Rab35-dependent cellular events.  Knockdown of a certain Rab35BP is insufficient to 
show whether a direct interaction between Rab35 and that Rab35BP is involved in 
cellular events, even when the Rab35BP knockdown impairs them.  The 
Rab35SR(T76S/T81A) mutant that I developed in this thesis on the other hand, is a 
useful tool for evaluating the functional significance of the Rab35–centaurin-β2 
interaction in cellular events.  By using this tool in combination with 
knockdown-rescue approaches, I succeeded in confirming our previous finding that the 
interaction between Rab35 and centaurin-β2 is essential for neurite outgrowth of PC12 
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cells, because the centaurin-β2-binding-deficient Rab35SR(T76S/T81A) mutant did not 
support NGF-induced neurite outgrowth of Rab35-knockdown cells (Figure 3).  
Similarly, the Rab35-binding-deficient centaurin-β2SR(N610A/N691A) mutant was 
unable to restore neurite outgrowth of centaurin-β2-knockdown cells (Figure 7). 
 In conclusion, I performed structure-function analyses of Rab35 and centaurin-β2 
by site-directed mutagenesis and identified residues that are crucial for the 
Rab35–centaurin-β2 interaction.  I also showed by knockdown-rescue experiments 
that centaurin-β2 functions as a Rab35 effector during NGF-induced neurite outgrowth 
of PC12 cells.  The Rab35SR(T76S/T81A) mutant that I developed should be a 
powerful, easy-to-use tool for probing involvement of centaurin-β2 in Rab35-dependent 
cellular events, including in cell migration (18) and phagocytosis (19), at the cellular 
level.  Actually, it has recently been shown by this mutant that the 
Rab35–centaurin-β2 interaction is required for podocalyxin trafficking to the apical 
membrane of a 2-dimensional MDCK monolayer (48). 
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FIGURE 1.  Identification of critical residues responsible for the specific binding 
of centaurin-β2 in the switch II region of Rab35 by site-directed mutagenesis. 
(A) Sequence alignment of the switch II regions of mouse Rab1A/B, Rab8A/B, Rab10, 
Rab13, Rab15, and Rab35.  Amino acid residues in the sequences that are conserved in 
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more than four switch II regions and that are similar are shown against a black 
background and a shaded background, respectively.  Only two amino acids 
(arrowheads) in the switch II region of Rab1A/B and Rab35 are different, and I replaced 
the Thr-76 and Thr-81 of Rab35 with Ser and Ala, respectively, by site-directed 
mutagenesis (i.e., produced a T76S/T81A mutant, which mimics the switch II region of 
Rab1A). 
(B) Summary of Rab35-binding proteins (Rab35BP) and their Rab-binding specificity.  
The Rab-binding specificity of all of the Rab35BPs except Fascin1 (#) has already been 
thoroughly investigated by yeast two-hybrid assays (7, 8, 12). 
(C) Centaurin-β2 specifically recognized Rab35, but did not recognize other Rabs that 
interact with MICALs, OCRL, and RUSC2.  Yeast cells containing 
pAct2-cenaurin-β2-ANKR and pGBD-C1-Rabs(QL)ΔCys (7) were streaked on SC-LW 
(top panels) and SC-AHLW (selection medium; bottom panels) and incubated at 30°C 
for one day and one week, respectively. 
(D) Two Thr residues of Rab35, Thr-76 and Thr-81, are critical for binding 
centaurin-β2, but not for binding other Rab35BPs.  Yeast cells containing the pAct2 
(or pGAD) plasmid expressing Rab35BP and pGBD plasmid expressing the constitutive 
active form (Rab35(QL)) of Rab35(WT) (wild-type) or Rab35(T76S/T81A) mutant 
were streaked on SC-LW (left panels) and SC-AHLW (right panels) and incubated at 
30°C for one day and one week, respectively. 
(E) The T76S/T81A mutation did not impair Facsin1 binding activity in 
co-immunoprecipitation assays.  T7-tagged Facsin1 and FLAG-tagged Rab35(WT) or 
Rab35(T76S/T81A) mutant were co-expressed in COS-7 cells, and their associations 
were analyzed by co-immunoprecipitation assays with anti-FLAG tag 
antibody-conjugated agarose beads as described previously (29, 31).  
Co-immunoprecipitated T7-tagged Facsin1 (middle panel) and immunoprecipitated 
FLAG-tagged Rab35(WT) or Rab35(T76S/T81A) mutant (bottom panel) were detected 
with HRP-conjugated anti-T7 tag antibody and HRP-conjugated anti-FLAG tag 
antibody, respectively.  The positions of the molecular mass markers (in kilodaltons) 
are shown on the left. 
(F) The T76S/T81A mutation dramatically decreased the centaurin-β2 binding activity 
of Rab35, a finding that was consistent with the results of the yeast two-hybrid assays 
shown in D.  Co-immunoprecipitation assays were performed as described in E. 
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FIGURE 2.  Involvement of the switch II region of Rab35 in the binding of 
Rab35BPs. 
(A) Sequence alignment of the switch II regions of mouse Rab5A and Rab35.  Amino 
acid residues that are conserved in the two sequences are shown against a black 
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background.  The central parts of their switch II region (dashed line) were swapped, 
and the Rab35(S5A) mutant contains part of the switch II region of Rab5A. 
(B) The switch II region of Rab35 is required for binding all Rab35BPs except RUSC2.  
Yeast two-hybrid assays were performed as described in the legend for Figure 1C. 
(C) The Rab35(S5A) mutant hardly interacted with centaurin-β2 at all, in contrast to the 
weak centaurin-β2 binding activity of the Rab35(T76S/T81A) mutant.  
Co-immunoprecipitation assays were performed as described in the legend for Figure 
1E.  The positions of the molecular mass markers (in kilodaltons) are shown on the 
left. 
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FIGURE 3.  Effect of the T76S/T81A mutation of Rab35 on NGF-induced neurite 
outgrowth of PC12 cells. 
(A) Typical images of PC12 cells (merged bright-field images and EGFP fluorescence 
images) transiently expressing shControl or shRab35 together with pEGFP-C1 (top 
row) or together with pEGFP-C1-Rab35SR(WT, T76S/T81A, or S5A) (bottom row).  
The cells were fixed after NGF stimulation for 36 h and examined under a confocal 
microscope.  Under my experimental conditions, manipulation of Rab35 had no 
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significant effect on the number of neurites (shControl, 2.2 ± 0.06; shRab35, 2.0 ± 0.04; 
shRab35 + Rab35SR(WT), 2.3 ± 0.06; shRab35 + Rab35SR(T76S/Y81A), 2.1 ± 0.05; 
and shRab35 + Rab35SR(S5A), 1.9 ± 0.05  (mean ± SEM)), suggesting that Rab35 is 
involved in neurite extension rather than in neuritogenesis.  Scale bars, 20 µm. 
(B) Quantification of total neurite length shown in A (sum of the lengths of the broken 
white lines in each PC12 cell).  The bars represent the means and SEM of data from 
three independent experiments (n = 100 cells; more than 30 cells were analyzed in each 
experiment).  ∗∗, p < 0.01; ∗∗∗, p < 0.001 (one-way ANOVA followed by the 
Tukey-Kramer test).  In contrast to the typical Rab35-knockdown cells shown in A, 
some EGFP-positive Rab35-knockdown cells still had longer neurites, presumably 
because of low knockdown efficiency, and the mean total neurite length of the 
Rab35-knockdown cells appeared to be overestimated. 
(C) Equivalent expression level of EGFP-Rab35SR(WT, T76S/T81A, or S5A) in 
shRab35-expressing PC12 cells.  Cell lysates of PC12 cells expressing shRab35 
together with EGFP-Rab35SR(WT, T76S/T81A, or S5A) were subjected to 12.5% 
SDS-PAGE followed by immunoblotting with anti-Rab35 antibody and anti-actin 
antibody.  The positions of the molecular mass markers (in kilodaltons) are shown on 
the left. 
40 
FIGURE 4.  Rab35-binding activity of the centaurin-β2 homologues, 
centaurin-β1 and centaurin-β5. 
(A) Schematic representation of the domain organization of centaurin-β1/ACAP1 
(Centβ1), centaurin-β2/ACAP2 (Centβ2), and centaurin-β5/ACAP3 (Centβ5). 
(B) Centβ2-ANKR, but not Centβ1-ANKR or Centβ5-ANKR, specifically recognized 
the active form of Rab35.  Yeast cells containing pAct2 plasmid expressing 
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Centβ1-ANKR, Centβ2-ANKR, or Centβ5-ANKR and pGBD plasmid expressing 
Rab35(QL) (a constitutive active form) or Rab35(SN) (a constitutive negative form) 
were streaked on SC-LW (left panels) and SC-AHLW (right panels) and incubated at 
30°C. 
(C) Centβ2-ANKR, but not Centβ1-ANKR or Centβ5-ANKR, interacted with Rab35 in 
COS-7 cells.  Co-immunoprecipitation assays were performed as described in the 
legend for Figure 1E.  The positions of the molecular mass markers (in kilodaltons) are 
shown on the left. 
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FIGURE 5.  Determination of the minimal Rab35-binding site in centaurin-β2.  
(A) Schematic representation of the deletion mutants of the ANKR domain of 
centaurin-β2 used in this thesis.  Amino acid (AA) numbers are shown on both sides of 
each construct.  The minimal Rab35-binding site (RBD35) determined in this thesis is 
indicated by enclosure with a broken line. 
43 
(B) Rab35 binding activities of the centaurin-β2 deletion mutants.  Yeast cells 
containing pAct2 plasmid expressing Centβ2-ANKR or each Centβ2-ANKR mutant 
(AA630–770, AA662–770, AA580–755, AA580–745, AA580–730, AA580–697, or 
AA630–730) and pGBD plasmid expressing Rab35(QL) were streaked on SC-LW (top 
panel) and SC-AHLW (bottom panel) and incubated at 30°C. 
(C) Rab35 binding activity of Centβ2-ANKR mutants (AA630–730, AA580–730, 
AA580–755, and AA580–745) in COS-7 cells.  Co-immunoprecipitation assays were 
performed as described in the legend for Figure 1E.  The positions of the molecular 
mass markers (in kilodaltons) are shown on the left. 
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FIGURE 6.  Identification of critical residues responsible for the binding of 
Rab35 in the ANKR domain of centaurin-β2 by site-directed mutagenesis. 
(A) Sequence alignment of the ANKR domains of mouse centaurin-β1 (Centβ1), 
centaurin-β2 (Centβ2), and centaurin-β5 (Centβ5).  Amino acid residues in the 
sequences that are conserved and that are similar are shown against a black background 
and a shaded background, respectively.  The arrowheads indicate the positions of 
amino acids that are not conserved between Centβ2 and Centβ1 or Centβ5 and were the 
focus of the Ala-based site-directed mutagenesis. 
(B) Rab35 binding activity of Centβ2 as determined by yeast two-hybrid assays.  
Yeast cells containing pAct2 plasmid expressing Centβ2-ANKR(WT) or each 
Centβ2-ANKR mutant (N610A, N632A, T648A, N691A, T695A/E697A, N724A, 
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S730A, L733A/Y734A, or Q764A/Q765A) and pGBD plasmid expressing Rab35(QL) 
were streaked on SC-LW (top panel) and SC-AHLW (bottom panel) and incubated at 
30°C.  Based on the growth rate of the yeast cells, the N610A, T648A, or N691A 
mutation in the Centβ2-ANKR appeared to slightly decrease Rab35 binding activity.  
(C) Two Asn residues, i.e., Asn-610 and Asn-691, of Centβ2-ANKR are critical for 
binding Rab35.  Yeast two-hybrid assays were performed as described in B. 
(D) The N610A/N691A mutation of Centβ2 dramatically decreased Rab35 binding 
activity, a finding that was consistent with the results of the yeast two-hybrid assays 
shown in C.  Co-immunoprecipitation assays were performed as described in the 
legend for Figure 1E.  The positions of the molecular mass markers (in kilodaltons) are 
shown on the left. 
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FIGURE 7.  Effect of the N610A/N691A mutation of centaurin-β2 on 
NGF-induced neurite outgrowth of PC12 cells. 
(A) Typical images of PC12 cells (merged bright-field images and EGFP fluorescence 
images) transiently expressing shControl or shcentaurin-β2 (shCentβ2) together with 
pEGFP-C1 (top row) or pEGFP-C1-Centβ2SR(WT, N610A/N691A, or ΔANKR) 
(bottom row).  The cells were fixed after NGF stimulation for 36 h and examined 
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under a confocal microscope.  Under my experimental conditions, manipulation of 
centaurin-β2 had no significant effect on the number of neurites (shControl, 2.2 ± 0.05; 
shCentβ2, 2.0 ± 0.04; shCentβ2 + Centβ2SR(WT), 2.1 ± 0.04; shCentβ2 + 
Centβ2SR(N610A/N691A), 2.0 ± 0.04; and shCentβ2 + Centβ2SR(ΔANKR), 2.0 ± 0.05 
(mean ± SEM)), suggesting that centaurin-β2 is involved in neurite extension rather 
than in neuritogenesis, the same as Rab35 is.  Scale bars, 20 µm. 
(B) Quantification of total neurite length shown in A (sum of the lengths of the broken 
white lines in each PC12 cell).  The bars represent the means and SEM of data from 
three independent experiments (n = 100 cells; more than 30 cells were analyzed in each 
experiment).  ∗∗, p < 0.01; ∗∗∗, p < 0.001 (one-way ANOVA followed by the 
Tukey-Kramer test). 
(C) Equivalent expression level of EGFP-Centβ2SR(WT, N610A/N691A, or ΔANKR) 
in shCentβ2-expressing PC12 cells.  Cell lysates of PC12 cells expressing shCentβ2 
together with EGFP-Centβ2SR(WT, N610A/N691A, or ΔANKR) were subjected to 
10% SDS-PAGE followed by immunoblotting with anti-Centβ2 antibody, anti-GFP 
antibody, and anti-actin antibody.  Because our anti-Centβ2 antibody recognized the 
C-terminal domain of centaurin-β2, it failed to detect EGFP-Centβ2SR(ΔANKR) 
expression (top panel, lane 5).  The positions of the molecular mass markers (in 
kilodaltons) are shown on the left. 
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Chapter 2 
 
Rab10 regulates tubular endosome formation 
through KIF13A/B motors 
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Abstract 
 
Recycling endosomes are stations that sort endocytic cargoes to their appropriate 
destinations.  Tubular endosomes have been characterized as a recycling endosomal 
compartment for clathrin-independent cargoes.  However, the molecular mechanism 
by which tubular endosome formation is regulated is poorly understood.  In this 
chapter, I identified Rab10 as a novel protein localized at tubular endosomes by using a 
comprehensive localization screen of EGFP-tagged Rab small GTPases.  Knockout of 
Rab10 completely abolished tubular endosomal structures in HeLaM cells.  We also 
identified kinesin motors KIF13A/B as novel Rab10-interacting proteins by means of in 
silico screening.  The results of this study demonstrated that both the Rab10-binding 
homology domain and the motor domain of KIF13A are required for Rab10-positive 
tubular endosome formation.  My findings provide insight into the mechanism by 
which the Rab10–KIF13A/B complex regulates tubular endosome formation. 
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Introduction 
 
Higher eukaryotic cells contain several functionally distinct endosomal 
compartments, including an early endosome (EE) and a recycling endosome (RE).  
Their endosomal compartments sort internalized proteins according to their destinations, 
e.g., lysosomes, the plasma membrane (PM), and the trans-Golgi network (TGN).  
REs were originally characterized as the interchange to recycle internalized cargoes, 
such as the transferrin receptor (TfR), from EEs to the PM (1).  The endosomal sorting 
machinery is essential for maintaining the homeostasis that underlies fundamental 
cellular functions such as intracellular signaling, cell migration, and polarity formation 
(2, 3). 
Recent studies have demonstrated the presence of another distinct RE 
compartment that is characterized by striking tubular-shaped structures (4, 5).  The 
tubular recycling endosomes, called tubular endosomes, have been shown to be 
involved in the clathrin-independent endocytic (CIE) pathway and not in the 
clathrin-mediated endocytic (CME) pathway (6, 7).  Tubular endosomes are thought to 
regulate the sorting and trafficking of CIE cargoes such as CD147 and not CME cargoes 
such as TfR (8, 9).  However, the significance of their tubular structure remains to be 
determined, in part because of lack of information about the molecular mechanism of 
tubular endosome formation. 
The Rab family of small GTPases are key regulators of membrane traffic that 
consist of approximately 60 members in mammals.  Since each Rab is thought to 
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regulate different intracellular membrane trafficking pathways, i.e., the secretory 
pathway, the endocytic pathway, and the recycling pathway, for CME cargoes (10–13), 
it seems reasonable to expect that a set of Rabs also functions in the formation of 
tubular endosomes.  Actually, several Rab family members, i.e., Rab8A, 11A, 22A, 
and 35, have been reported to regulate tubular endosome formation (14–17).  However, 
the full repertoire of tubular-endosome-resident Rabs and their roles in tubular 
endosomes remain to be determined. 
 In this chapter, I performed a comprehensive localization screening of the Rab 
subfamily and succeeded in identifying Rab10 as a novel protein predominantly 
localized at tubular endosomes.  Intriguingly, knockout of Rab10 completely disrupted 
the formation of tubular endosomes.  I also identified kinesin motors KIF13A/B as 
novel Rab10-interacting proteins by means of in silico screening and found that their 
knockout also disrupts tubular endosome formation.  My findings suggest that the 
Rab10–KIF13 complex regulates the formation of tubular endosomes through its motor 
activity along microtubule tracks. 
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Materials and Methods 
 
Materials 
Anti-Rab22A rabbit polyclonal antibody was raised against GST-Rab22A (18) as 
an antigen and purified as described previously (19).  The following commercially 
available antibodies were used in this study: anti-human Lamp1 (clone H4A3, 
sc-20011) and anti-c-Myc (9E10, sc-40) mouse monoclonal antibodies from Santa Cruz 
Biotechnology (Dallas, TX); HRP-conjugated FLAG tag mouse monoclonal antibodies 
(M2, A8592) from Sigma-Aldrich (St. Louis, MO); anti-β-actin mouse monoclonal 
antibody (G043) from Applied Biological Materials (Richmond, BC, Canada); 
anti-Rab8 (610845; reacting with both Rab8A and Rab8B) and anti-GM130 mouse 
monoclonal antibodies (35/GM130, 610822) from BD Biosciences (San Jose, CA); 
anti-Rab10 (clone D36C4, 8127), anti-Rab8 rabbit (clone D22D8, 6975; for 
immunofluorescence), and anti-EEA1 rabbit monoclonal antibodies (clone C45B10, 
3288) from Cell Signaling Technology (Danvers, MA); anti-Rtn4/NogoA rabbit 
monoclonal antibody (AHP1799) from Bio-Rad (Hercules, CA); anti-LBPA mouse 
monoclonal antibody (clone 6C4, Z-PLBPA) from Echelon Biosciences (Salt Lake City, 
UT); anti-LC3 (PM036) and anti-GFP (598) rabbit polyclonal antibodies from MBL 
(Woburn, MA); mouse anti-MICAL-L1 (H00085377-B01P) from Abnova (Taipei, 
Taiwan); anti-KIF13A (A301-077A) rabbit polyclonal antibody from Bethyl 
Laboratories (Montgomery, TX); anti-CD147 mouse monoclonal antibody (clone HIM6, 
306202) from Biolegend (San Diego, CA); anti-KIF13B rabbit polyclonal antibody 
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(NBP1-83398) and anti-Rab22B/31 mouse monoclonal antibody (1C6, 
H00011031-M01) from Novus Biologicals (Littleton, CO) ; anti-RFP rabbit polyclonal 
antibody (600-401-379) from Rockland (Gilbertsville, PA) ; anti-TGN46 rabbit 
polyclonal antibody (ab50595) from Abcam (Cambridge, MA) ; anti-HA rat polyclonal 
antibody (3F10, 11867423001) from Roche Diagnostics (Indianapolis, IN); anti-TfR 
mouse monoclonal antibody (clone H68.4, 13-6800), and Alexa Fluor–labeled 
secondary antibodies from Thermo Fisher Scientific (Waltham, MA). 
 
Plasmid Construction 
The pMRX-IRES-puro retroviral vector was a kind gift from Shoji Yamaoka (20).  
cDNAs encoding the mouse Rabs (1A, 2A, 3A, 4A, 5A, 6A, 7, 7B/42, 8A, 9A, 10, 11A, 
12, 13, 14, 15, 17, 18, 19, 20, 21, 22A, 23, 24, 25, 26, 27A, 28, 29, 30, 32, 33A, 34, 35, 
36, 37, 38, 39A, 40C, 42/43, and 43/41) (21) were subcloned into the 
pMRX-puro-EGFP vector.  cDNAs encoding Rab10, Rab8A, and Rab22A were 
subcloned into the pMRX-bsr vector or the pMRX-bsr-Myc vector.  cDNA encoding 
EMTB (AA153-419 of human MAP7, transcript variant 4) was amplified from 
Marathon-Ready human testis cDNA (Clontech-Takara Bio, Shiga, Japan) by PCR with 
the following pair of oligonucleotides: 
5’-GTCCGGACTCGGATCCGCAGTGCGAAGCGAAACAG-3’ (forward primer; 
homologous sequence with the 3’ end of the linearized vector underlined) and 
5’-ATTTACGTAGCGGCCCTAAGAGCCCTCAGGTGGTGTT-3’ (reverse primer; 
homologous sequence with the 5’ end of the linearized vector underlined), and 
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subcloned into the pMRX-puro-EGFP vector and pMRX-bsr-mStr vector with an 
In-Fusion HD cloning kit (Clontech-Takara Bio).  cDNA encoding LifeAct-mCherry 
(kindly provided by Dr. Kazumasa Ohashi, Tohoku University) was subcloned into the 
pMRX-bsr vector.  cDNAs encoding the tail domains of mouse KIF13A and KIF13B 
were prepared as described previously (22).  cDNAs encoding the motor domains of 
mouse KIF13A and KIF13B were amplified from Marathon-Ready mouse brain and 
testis cDNAs (Clontech-Takara Bio) by PCR with the following pairs of 
oligonucleotides: 5’-GGATCCATGTCGGATACGAAGGTAAA-3’ (Kif13A motor 
forward primer; BamHI site underlined) and 
5’-CCGCGGAACTGGTTTCTCTCTCAA-3’ (Kif13A motor reverse primer); 
5’-AGATCTATGGGAGACTCCAAAGTGAA-3’ (Kif13B motor forward primer; 
BglII site underlined) and 5’-CAGATCTCGGATAATCCGAG-3’ (Kif13B motor 
reverse primer).  cDNAs encoding the full length of mouse KIF13A and KIF13B were 
prepared by combining their motor domain and tail domain constructs, and subcloned 
into the pMRX-puro HA vector or pMRX-bsr Myc vector.  cDNAs encoding mouse 
KIF13A/B (ΔRHD10) mutants were prepared by inverse PCR using a 
KIF13A/B-harboring vector as a template and the following pairs of oligonucleotides: 
5’-CCGATGCAGTGCTGGTGCCCGCCCCTGGCAGCG-3’ (KIF13A ΔRHD10 
forward primer) and 5’-CCAGCACTGCATCGGACCATCTCTCTCTTACA-3’ 
(KIF13A ΔRHD10 reverse primer); 
5’-TCAATGCAGTGATGGTGCCTTCTGCTGGGAGTG-3’ (KIF13B ΔRHD10 
forward primer) and 5’-CCATCACTGCATTGAGCCATTTTCTACGAAGC-3’ 
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(KIF13B ΔRHD10 reverse primer).  pGEX-6P-1-GFP-nanobody (23) was kindly 
provided by Dr. Kazuhisa Nakayama (Kyoto University). 
 
Cell Culture, Transfection, Infection, and Drug Treatment 
HeLaM cells, COS-7 cells, and Plat-E cells (a kind gift from Dr. Toshio Kitamura, 
The University of Tokyo) were grown at 37°C in Dulbecco’s modified Eagle medium 
(D-MEM) (044-29765; FUJIFILM Wako Pure Chemical, Osaka, Japan) supplemented 
with 10% fetal bovine serum (FBS), 100 U/ml penicillin G, and 100 µg/ml streptomycin 
in a 5% CO2 incubator.  For live-cell imaging, D-MEM with HEPES (044-32955; 
FUJIFILM Wako Pure Chemical) was used instead of D-MEM with phenol red.  
Transfection of plasmids into HeLaM cells and Plat-E cells was performed by using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol.  To 
establish stable cell lines, retrovirus production in Plat-E cells and retrovirus infection 
were performed as described previously (24).  Plasmid mixtures containing pMRX 
vector and pLP/VSVG (Thermo Fisher Scientific, MA) were transfected into Plat-E 
cells, and the culture medium containing the desired retroviruses was collected.  
HeLaM cells were infected by using the retrovirus-containing medium and 5 µg/ml 
polybrene.  Stable cell lines were selected by using puromycin (2 µg/ml for 48 h, 
Merck Millipore, MA) and blasticidin S (5 µg/ml for 24 h, FUJIFILM Wako Pure 
Chemical).  Cells were exposed for 1 h to 10 µM cytochalasin D or 10 µg/ml 
nocodazole under the above culture conditions. 
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CRISPR/Cas9 Gene KO 
Rab8A/B-, Rab10-, Rab22A/B-, KIF13A-, KIF13B-, and KIF13A/B-KO HeLaM 
cell lines were established by means of the following procedures.  
pSpCas9(BB)-2A-Puro vector (Addgene; #48139) was used to generate a single guide 
RNA (sgRNA).  The following sgRNA sequences were designed by using the 
CRISPRdirect website (http://crispr.dbcls.jp/): sgRNA sequences targeting human 
Rab8A (sense, 5’-CACCGATTAGGACCATAGAGCTCGA-3’ and antisense, 
5’-AAACTCGAGCTCTATGGTCCTAATC-3’); human Rab8B (sense, 
5’-CACCGCTCCTGCTGATCGGCGACTC-3’ and antisense, 
5’-AAACGAGTCGCCGATCAGCAGGAGC-3’); human Rab10 (sense, 
5’-CACCGGATCGGGGATTCCGGAGTGG-3’ and antisense, 
5’-AAACCCACTCCGGAATCCCCGATCC-3’); human Rab22A (sense, 
5’-CACCGTTAGCACCAATGTACTATCG-3’ and antisense, 
5’-AAACCGATAGTACATTGGTGCTAAC-3’); human Rab22B (sense, 
5’-CACCGCATCGTGTGTCGATTTGTCC-3’ and antisense, 
5’-AAACGGACAAATCGACACACGATGC-3’); human KIF13A (sense, 
5’-CACCGGATATGCAGACCGAGCCAAA-3’ and antisense, 
5’-AAACTTTGGCTCGGTCTGCATATCC-3’); and human KIF13B (sense, 
5’-CACCGAGTGAACGAGCAACGAAGAC-3’ and antisense, 
5’-AAACGTCTTCGTTGCTCGTTCACTC-3’).  The sgRNA expression constructs 
were transfected into HeLaM cells, and 24 h later 2 µg/ml puromycin (Merck Millipore) 
was added to the culture medium to select transfected cells.  Puromycin was removed 
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after an additional 48 h, and the cells were cloned by limited dilution.  Clonal lines 
were isolated and analyzed by immunoblotting with a specific antibody to check for 
absence of expression of target proteins. 
 
Purification of GST Fusion Proteins 
GST-tagged GFP nanobody was expressed in Escherichia coli JM109 and 
purified as described previously (25). 
 
Immunoblot Analysis 
HeLaM cells were lysed in an SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% 
2-mercaptoethanol, 10% glycerol, and 0.02% bromophenol blue) and boiled.  The 
samples were subjected to SDS-PAGE and then transferred to polyvinylidene difluoride 
membranes (Merck Millipore).  The membranes were blocked with PBS-T (0.1% 
Tween 20 in PBS) containing 1% skim milk and incubated for 1 h with specific primary 
antibodies.  The membranes were subsequently incubated for 1 h with appropriate 
HRP-conjugated secondary antibodies, and immunoreactive bands were detected by 
using enhanced chemiluminescence and X-ray films or the ChemiDoc Touch imaging 
system (Bio-Rad). 
 
Co-immunoprecipitation Assays 
COS-7 cells co-expressing mStr-Rab10 and EGFP or EGFP-tagged KIF13(A or 
B)-tail were lysed in a lysis buffer (50 mM HEPES-KOH, pH 7.2, 150 mM NaCl, 10 
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mM MgCl2, 1% Triton X-100, and protease inhibitor cocktail; Roche, Basel, 
Switzerland).  The lysates were centrifuged at 17,400 × g for 10 min at 4°C, and the 
supernatants were incubated for 1 h at 4°C with 5 µl of glutathione-Sepharose 4B beads 
(wet volume) (GE Healthcare, Little Chalfont, UK) and 1µg of GST-tagged GFP 
nanobody.  The beads were washed with a washing buffer (50 mM HEPES-KOH, pH 
7.2, 150 mM NaCl, 10 mM MgCl2, and 0.1% Triton X-100) three times and boiled in 
the SDS sample buffer.  The samples then were subjected to SDS-PAGE and analyzed 
by immunoblotting with appropriate antibodies. 
 
Immunofluorescence Microscopy 
For the immunofluorescence analysis, cells were cultured on coverslips, fixed 
with 4% paraformaldehyde in PBS for 10 min, and permeabilized for 10 min with 
0.05% saponin in PBS containing 0.1% gelatin.  The coverslips were incubated for 1 h 
with primary antibodies and subsequently incubated for 1 h with appropriate Alexa 
Fluor-conjugated secondary antibodies.  The samples were mounted using ProLong 
Gold Antifade Mountant (Thermo Fisher Scientific).  The stained cells were captured 
with an FV1000D confocal fluorescence microscope through a 60× oil/1.4 NA Plan 
Apochromatic objective lens and Fluoview software (Olympus, Tokyo, Japan).  
Super-resolution images were acquired by using the OSR system (Olympus) of an 
FV1000D confocal fluorescence microscope. 
 
Live-cell imaging 
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Live-cell imaging was performed with an Andor Dragonfly spinning disk scanning unit 
(Dragonfly200) or a Zeiss Yokogawa spinning disk scanning unit (CSU-W1) coupled 
with an inverted Olympus IX83 microscope equipped with a 60× oil/1.35 NA Plan 
Apochromatic objective lens.  During live-cell imaging, the culture dish was mounted 
in a chamber (STRG-WELSX-SET; Tokai Hit, Shizuoka, Japan, or 
STXG-IX3WX-SET; Tokai Hit) to maintain the cells at 37°C and under a 5% CO2 
atmosphere. 
 
Quantification of Tubular Endosomes 
The number of cells containing at least one tubule >20 µm in length was manually 
measured.  The number of cells containing at least one tubule >20 µm in length was 
counted in each experiment (more than 20 cells were analyzed in each experiment).  
Total tubule length (i.e., sum of the length of all tubules) per cell was measured by 
using Fiji (https://fiji.sc) and the population profile was created (Figure 4H).   
Maximum intensity z-projected images were binarized and then skeletonized by 
LpxLineExtract, which is invoked by Lpx_Filter2d plug-ins (filter = lineFilters, 
linemode = lineExtract) in the LPixel ImageJ plugins package 
(https://lpixel.net/services/research/lpixel-imagej-plugins/) (26).  The >5 µm 
skeletonized lines in the images were extracted by using the analyze particles function 
in Fiji.  Total tubule length in each cell was measured by using the measure function in 
Fiji, and a histogram analysis of the data was performed by using the Excel software 
program (Microsoft, Redmond, WA). 
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Colocalization Analysis 
The PCC values were calculated for more than 4 maximum intensity z-projected 
images from each experiment by using Coloc 2, a Fiji plugin for colocalization analysis 
(http://imagej.net/Coloc_2).  The line plot profile of the yellow arrows in Figures 1E 
and 5A was obtained by using the plot profile function in Fiji. 
 
Bioinformatics Analysis 
The RHD10 of KIF13A/B was identified by using the RBD10 of MICAL1 
(isoform 3 of human: AA939-1080) or EHBP1 (isoform 1 of human: AA1070-1212) as 
a search query in PSI-BLAST searches, followed by a DELTA-BLAST search.  The 
3D-homology modeling of the RHD10 of KIF13A was performed by using the 
Modeller9.19 software (27), incorporated in the UCSF Chimera interactive graphic 
interface (28).  Rab10–MICAL1 complex (PDB: 5LPN) was used as a template. 
 
Statistical Analysis 
All quantitative data are expressed as the means and SEM.  Tukey’s test, 
Dunnett’s test, unpaired Student’s t test, and Pearson’s χ2 test were performed to 
evaluate the statistical significance of differences between samples.  P values <0.05 
were regarded as statistically significant. 
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Results 
 
Comprehensive Localization Screening for EGFP-Rabs Identified Rab8 and Rab10 
as Specific Markers for Tubular Endosomes 
To prepare a list of Rabs that specifically localize at tubular endosomes, I 
established a library of HeLaM cells that stably express EGFP-tagged Rab subfamily 
members (Rab1A–43) and performed a localization screening.  First, I defined a 
tubular endosome as a tubular structure >20 µm in length and manually counted the 
number of cells containing at least one EGFP-positive tubular endosome (Figure 1A and 
1B, blue bars).  Second, I immunostained HeLaM cells with antibody against 
MICAL-L1, a well-known tubular endosome marker (14) and then calculated Pearson’s 
correlation coefficient (PCC) values for the relation between EGFP-Rabs and 
MICAL-L1 (Figure 1A and 1B, orange bars).  The results showed that 10 of the Rab 
subfamily members tested, i.e., Rab5A, 8A, 10, 11A, 13, 17, 21, 22A, 23, and 35, were 
localized at tubular endosomes, but that neither EGFP alone nor EGFP-Rab1A was 
associated with tubular endosomes (Figure 1B, blue bars, and Figure 2).  It should be 
noted that tubules positive for 8 Rabs (Rab8A, 10, 11A, 13, 17, 22A, and 35) were 
colocalized with MICAL-L1, but that Rab5A-positive tubules and Rab21-positive 
tubules were not (Figure 2), suggesting the presence of subdomains in the tubular 
endosomes.  Because these tubular-endosome-resident Rabs are known to localize at 
REs, EEs, and/or the PM (29–38), tubular endosomes are likely to be part of recycling 
pathways, as described previously (5).  Consistent with previous reports (8, 15, 16), 
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tubular localization of Rab8A/11A/22A was also observed, thereby validating the 
results of my screenings.  Two of the tubular-endosome-resident Rabs I identified, 
Rab8 and Rab10 showed higher values with respect to the percentage of cells with 
Rab-positive tubular endosomes (more than 80%) and to the PCC value for the relation 
between EGFP-Rabs and MICAL-L1 (more than 0.4) (Figure 1B), and I therefore 
decided to focus on them for further analysis. 
Because Rab10 had previously been shown to be localized at REs, the TGN, or 
endoplasmic reticulum (ER) in other cell types (31, 39, 40), I investigated the 
subcellular localization of endogenous Rab8 and Rab10 in HeLaM cells.  The same as 
EGFP-Rab8 and -Rab10, I found that endogenous Rab8 and Rab10 were well 
colocalized with MICAL-L1 at tubular endosomes (Figures 1C–D and 2).  I also 
compared the localization of EGFP-Rab10 with several organelle markers to determine 
its subcellular localization.  The results showed that EGFP-Rab10 was significantly 
colocalized with MICAL-L1 (PCC = 0.51 ± 0.04) as compared with TGN46 (a TGN 
marker; PCC = 0.32 ± 0.03), GM130 (a cis-Golgi marker; PCC = 0.26 ± 0.04), TfR (an 
RE marker; PCC = 0.04 ± 0.03), EEA1 (an EE marker; PCC = 0.13 ± 0.04), LC3 (an 
autophagosome marker; PCC = 0.05 ± 0.05), LAMP1 (a lysosome marker; PCC = 0.04 
± 0.01), LBPA (a late endosome [LE] marker; PCC = 0.04 ± 0.03), or RTN4 (an ER 
marker; PCC = -0.03 ± 0.04) (Figure 3A and 3B), confirming that Rab10 mainly marks 
tubular endosomes rather than conventional TfR-positive REs in HeLaM cells.  
Although Rab10 was partially colocalized with TGN46, brefeldin A treatment, which 
disrupts the Golgi complex, did not affect the EGFP-Rab10-positive tubules (Figure 3C 
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and 3E), but it resulted in a decrease in the PCC for the relation between EGFP-Rab10 
and TGN (PCC = 0.04 ± 0.03) (Figure 3D).  These results suggest that 
EGFP-Rab10-positive tubules are distinct from the tubular carriers in the TGN, which is 
a part of the pathway for newly synthesized proteins (41).  The discrepancy between 
the Rab10-localization results obtained in this study (HeLaM cells) and previous studies 
(other cell types) may be explained by Rab10 localization being cell- or tissue-specific. 
To determine whether Rab10-positive tubules preferentially transport CIE cargoes 
rather than CME cargoes, I compared EGFP-Rab10 localization with the localization of 
Tf and CD147, which are internalized into the RE via the CME pathway and the CIE 
pathway, respectively.  To do so, I observed HeLaM cells stably expressing 
EGFP-Rab10 that had internalized both Alexa594-Tf and anti-CD147 antibody.  The 
results showed that EGFP-Rab10 clearly colocalized with the internalized CD147 at 
tubular endosomes and did not colocalize with the internalized Tf (Figure 1E and 1F).  
These results are consistent with previous reports that tubular endosomes contain CIE 
cargoes, not CME cargoes. 
 
Rab10 Is Required for Tubular Endosome Formation and its Dynamics Depends on 
Microtubules 
To determine whether Rab8 and Rab10 are required for tubular endosome 
formation and reveal their relationships, I generated Rab8A/B-double knockout 
(Rab8-DKO) and Rab10-knockout (Rab10-KO) cell lines by using the CRISPR/Cas9 
system (Figure 4A and 4B) and examined the Rab8-DKO cells for the presence of 
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EGFP-Rab10-positive tubules and the Rab10-KO cells for the presence of 
EGFP-Rab8-positive tubules.  EGFP-Rab10-positive tubules were still observed in the 
Rab8-DKO cells, and their overall localization was unaltered even in the Rab8-DKO 
cells stably re-expressing Myc-Rab8A (Figure 4C and 4E).  These results were 
consistent with the previous finding that Rab8 itself is dispensable for tubular endosome 
formation (14, 42). By contrast, Rab10 KO resulted in complete dispersion of both the 
Rab8- and MICAL-L1-positive tubules (Figure 4D, top panels, and Figure 5A), and 
re-expression of Rab10 in Rab10-KO cells clearly rescued this phenotype (Figure 4D, 
bottom panels, 4F, and 4G).  On the other hand, Rab10 KO had no effect on the level 
of Rab8 expression or MICAL-L1 expression (Figure 4B), indicating that Rab10 KO 
causes disruption of both tubules without affecting the levels of expression of tubular 
components.  To quantitatively evaluate the difference between Rab10-KO cells and 
Rab10-KO cells stably re-expressing Rab10, I measured the total length of 
MICAL-L1-positive tubules in each cell.  The results showed a significant difference 
between the population profile of total tubule length of Rab10-KO cells and Rab10-KO 
cells stably re-expressing cells (Figure 4H).  Intriguingly, other 
tubular-endosome-resident Rabs, i.e., EGFP-Rab5A, -Rab11A, -Rab13, and -Rab22A 
(Figure 1B and 1C), as well as Rab8A were not localized at the tubular endosomes in 
Rab10-KO cells (Figure 5A), suggesting that Rab10 is an essential constituent of 
tubular endosomes.  To determine the hierarchical relationship between Rab10 and 
Rab22A, a regulator of tubular endosomes (16), I generated a Rab22A/B-double 
knockout (Rab22-DKO) cell line (Figure 5B) and examined the effects of Rab22A/B 
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depletion on EGFP-Rab10 localization.  The results showed that Rab22A/B are 
required for the formation of EGFP-Rab10-positive tubules (Figure 5C and 5D), 
although Rab10 is also necessary for the formation of EGFP-Rab22A-positive tubules 
(Figure 5A).  These results indicate that Rab10 and Rab22A/B cooperatively regulate 
tubular endosome formation. 
To evaluate tubular endosome dynamics, I performed live-cell time-lapse imaging 
of HeLaM cells stably expressing EGFP-Rab10.  Examination of the images revealed 
that EGFP-Rab10-positive tubules are highly dynamic structures that frequently extend, 
branch, and retract (Figure 6A).  Previous studies have shown that actin filaments, not 
microtubules, are required for Rab10-binding protein EHBP1-positive tubules in the 
intestinal epithelium of C. elegans (43), whereas microtubules, not actin filaments, are 
required for the formation of Rab11A- and Rab22A-positive tubules in HeLa cells (5, 
15).  To determine whether the formation of Rab10-positive tubules in HeLaM cells 
depends on actin filaments or microtubules, I treated the cells with cytochalasin D and 
nocodazole, which are inhibitors of actin polymerization and microtubule 
polymerization, respectively.  Cytochalasin D treatment disrupted actin filaments, but 
dynamic tubular endosomes were still observed (Figure 6B and 6C), whereas 
nocodazole treatment dispersed the EGFP-Rab10-positive tubules into the cytoplasm 
(Figure 6A and 6B).  Consistent with these results, EGFP-Rab10-positive tubules were 
well colocalized with mStr (monomeric Strawberry)-EMTB (Figure 6D, arrowheads), 
which is an ensconsin microtubule-binding domain that can be used as a microtubule 
probe (44).  Moreover, EGFP-EMTB localization in Rab10-KO cells seemed unaltered 
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in comparison with its localization in parental cells or Rab10-KO cells stably 
re-expressing Rab10 (data not shown), indicating that the disruption of tubular 
endosomes in Rab10-KO cells is not caused by microtubule depolymerization.  These 
results taken together indicate that tubular endosomes are formed in a 
microtubule-dependent manner. 
 
KIF13A/B are Novel Rab10-interacting Proteins 
Since Rab proteins are generally thought to regulate membrane trafficking 
through the functions of their effectors, I focused my attention on the effectors of Rab10 
as a means of gaining insight into the molecular mechanism by which Rab10 regulates 
tubular endosome formation (11).  Because microtubules are required for tubular 
endosome formation (Figure 6B and 6C), I hypothesized that microtubule-associated 
Rab10 effectors are involved in the process.  I initially investigated previously 
reported Rab10 effectors, including proteins containing a bivalent MICAL/EHBP Rab 
binding domain (MICAL1, MICAL3, MICAL-cl, MICAL-L1, MICAL-L2, EHBP1, 
EHBP1L1, and C16orf45) (45), myosin-Va/b (39, 46), JIP1 (47), Sec16A (48), Evi5 
(49), and Lgl1 (50), but I was unable to identify any good candidates, because 
siRNA-mediated knockdown of these Rab10 effectors had no effect on the formation of 
EGFP-Rab10-positive tubules (data not shown).  
To identify a novel Rab10 effector(s) that associates with microtubules, I 
performed in silico screening.  I performed DELTA-BLAST searches by using the 
known Rab10-binding domain (RBD10) of MICAL1 or EHBP1 (45) as bait, followed 
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by PSI-BLAST, and then selected microtubule-associated proteins among the candidate 
Rab10 effectors.  By so doing I succeeded in obtaining a list of proteins containing an 
RBD10 homology domain, named RHD10, and identified the molecular motors 
KIF13A/B as candidates for novel Rab10 effectors that interact with microtubules 
(Figure 7A). 
KIF13A/B belong to the kinesin-3 family, which is evolutionarily conserved in 
higher eukaryotes and whose members function as organelle transporters in the dimer 
state (51, 52).  The sequential BLAST search showed that the amino acid (AA) 
sequence AA1102–1146 of KIF13A and AA sequence AA1099–1143 of KIF13B are 
similar to both RBD10s of MICAL1 and EHBP1 (Figure 7A, orange lines, and 7B).  
To structurally compare the RHD10 of KIF13A and RBD10 of MICAL1, I performed 
3D-homology modeling of the RHD10 based on the crystal structure of the 
Rab10–MICAL1 complex (PDB: 5LPN) by using MODELLER software (27).  As 
expected, the RHD10 of KIF13A overlapped the Rab10-binding region of the RBD10 
of MICAL1 (Figure 7C).  To confirm the interaction between Rab10 and KIF13A, I 
transiently co-expressed EGFP-KIF13A/B-tail, which contain the RHD10 (Figure 7D), 
and mStr-Rab10 in COS-7 cells and evaluated their interaction by immunoprecipitation 
using glutathione-Sepharose beads coupled with a GST-fused GFP nanobody.  The 
results showed that EGFP-KIF13A/B, not EGFP alone, interacted with mStr-Rab10 
(Figure 7E, top panel), indicating that KIF13A/B are novel Rab10-interacting proteins. 
 Next, I investigated the subcellular localization of Myc-KIF13A in HeLaM 
cells.  Consistent with the results of the co-immunoprecipitation assays (Figure 7E), 
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Myc-KIF13A was well colocalized with EGFP-Rab10 at tubular endosomes (Figure 8A 
and 8B).  By contrast, a KIF13A(ΔRHD10) mutant that lacks an RHD10 (Figure 8C), 
had lost the ability to localize at Rab10-positive tubules (Figure 8A, 8B, and 8D).  
Similarly, EGFP-KIF13B-tail(WT), but not the ΔRHD10 mutant, was colocalized with 
mStr-Rab10 at tubular endosomes (Figure 9A and 9B).  To determine whether the 
tubular endosome localization of KIF13A depends on Rab10, I investigated its 
localization in Rab10-KO cells.  As expected, the same as the KIF13A(ΔRHD10) 
mutant in the parental cells, the Myc-KIF13A in the Rab10-KO cells did not localize at 
any tubular structures at all (Figure 8E and 8F), although Rab10-KO itself did not affect 
the level of KIF13A/B expression (Figure 8G).  These results suggest that KIF13A/B 
are localized at tubular endosomes through their Rab10-interaction. 
 
Both the Rab10-binding Homology Domain and the Motor Domain of KIF13A Are 
Required for Tubular Endosome Formation 
Previous studies have shown that certain kinesin motors together with 
microtubules contribute to organelle tubulation through their motor activity along 
microtubule tracks (53, 54).  I therefore hypothesized that KIF13A/B regulate the 
tubulation of Rab10-resident endosomes through their motor activity.  To test this 
hypothesis, I established KIF13A-KO, KIF13B-KO, and KIF13A/B-DKO cell lines 
(Figure 10A) and examined the tubular endosomes in these cells.  The results showed 
that neither KIF13A-KO cells nor KIF13A/B-DKO cells contained MICAL-L1-positive 
tubules (Figure 10B and 10C), the same as Rab10-KO cells, which also lacked 
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MICAL-L1-positive tubules (Figure 4D).  There were also fewer MICAL-L1-positive 
tubules in the KIF13B-KO cells, but the phenotype was much less severe than that of 
the KIF13A-KO cells (Figure 10C), indicating that KIF13A plays the predominant role 
in tubular endosome formation.  To further investigate the functional redundancy of 
KIF13A/B, I evaluated the effect of KIF13B overexpression on tubular endosomes in 
KIF13A-KO cells.  The results showed that KIF13B overexpression in KIF13A-KO 
cells rescued the dispersion of tubular endosomes, the same as KIF13A overexpression 
had (Figure 11), suggesting that KIF13A/B have redundant functions in tubular 
endosome formation.  The level of KIF13B expression in HeLaM cells may be much 
lower than that of KIF13A, or KIF13A may have greater ability to facilitate tubule 
formation than KIF13B does, even if their expression level in HeLaM cells is similar. 
To further define the importance of the RHD10 and motor activity of KIF13A in 
tubular endosome formation, I re-expressed KIF13A mutants (ΔRHD10 and tail, which 
lacks an N-terminal motor domain; see also Figures 7D and 8C, respectively) in 
KIF13A-KO cells.  EGFP-Rab10 was not localized at tubular endosomes in 
KIF13A-KO cells, and re-expression of KIF13A(WT) clearly rescued this phenotype 
(Figure 10D and 10F).  By contrast, re-expression of neither KIF13A mutant (tail or 
ΔRHD10) restored EGFP-Rab10-positive tubular endosomes (Figure 10D and 10F), 
even though equivalent amounts of proteins were expressed under my experimental 
conditions (Figure 10E).  I therefore concluded that both the RHD10 and the motor 
domain of KIF13A are required for tubular endosome formation in HeLaM cells. 
70 
Discussion 
 
In the present thesis, I performed a comprehensive localization screening for Rabs 
that are localized on tubular endosomes and succeeded in identifying 10 Rabs, including 
6 novel ones.  One of them, Rab10, and its interactor KIF13A/B motors were found to 
be essential factors for the formation of tubular endosomes in HeLaM cells.  Because 
Rab10-positive tubular endosomes are sensitive to nocodazole (Figure 6B) and likely 
depend on KIF13A/B motor activity (Figure 10), I propose the following model for 
tubular endosome formation (Figure 12A): Rab10 recruits KIF13A/B to recycling (or 
early) endosomes, and the Rab10–KIF13 complex together with microtubules facilitates 
tubulation through KIF13 motor activity.  Although several kinesin-3 family members 
(e.g., KIF1) are known to interact with organelles through their lipid-binding domains, 
e.g., a pleckstrin homology (PH) domain (52), KIF13A/B lack such a domain.  Thus, 
Rab10 is likely to function as a molecular scaffold for the recruitment of KIF13A/B to 
tubular endosomes.  Moreover, the motor activity of KIF13A has been shown to 
mediate vesicle tubulation in vitro (54), a finding that supports the validity of my 
model. 
How do the Rabs that localize at tubular endosomes contribute to their formation 
or functions?  Based on the results of previous studies on the functions of tubular 
endosomal Rabs taken together with my own findings in the present study, I propose a 
model that would explain how these Rabs coordinate tubular endosome formation 
(Figure 12B).  Since tubular endosome formation has previously been shown to be 
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involved in the Arf6-dependent endocytic pathway for CIE cargoes (55, 56), it seems 
reasonable to expect the origin and the fate of tubular endosomes or CIE cargoes to be 
as follows: formation of CIE-cargo-carrying vesicles from the PM (Step 1); 
vesicle-to-tubular endosome transition (Step 2); CIE cargo sorting/transport to the PM, 
other RE compartments (e.g., Tf-positive RE), or the TGN (Step 3) (Figure 12B). 
My Rab localization screen identified novel MICAL-L1-positive tubular- 
endosome-resident Rabs (Rab10, 13, 17, and 23) in addition to the known Rabs (Rab8A, 
11A, 22A, and 35).  Rab13 and Rab35 are likely to participate in Step 1, because they 
are mainly localized at the PM (57, 58) and regulate certain types of Arf6-dependent 
endocytosis (59, 60).  In Step 2, EE-resident Rab22A, in addition to Rab10, is 
indispensable for tubular endosome formation (Figure 5D).  In Step 3, membrane 
scission must occur before CIE cargo sorting/transport to other organelles (Figure 6A).  
I think that Rab8 is the most likely candidate for the regulator in this process, because it 
is known to form a complex with EHBP1L1–Bin1–dynamin and regulates membrane 
scission (42).  Rab11 and Rab17 may also be involved in Step 3 (or Step 2), because 
they are mainly localized at Tf-positive REs and regulate its trafficking (32, 61).  It 
should be noted that Rab11 also interacts with KIF13A through the C-terminal region, 
which does not contain the RHD10 region (62), although Rab11 itself is not necessary 
for tubular endosome formation (15, 16).  I therefore speculate that KIF13A initially 
interacts with Rab10 in the process of tubular endosome formation and then interacts 
with Rab11A in the process of CIE cargo sorting/transport from tubular endosomes.  
Further studies will be necessary to fully understand the functional relationships or 
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hierarchy of tubular-endosome-resident Rabs in tubular endosome formation and 
function. 
What is the physiological role of Rab10-positive tubular endosomes?  There are 
two tasks that must be accomplished to answer this question: one task is compiling the 
entire list of tubular endosome cargoes and the other task consists of identifying specific 
cells that contain tubular endosomes in vivo.  A certain acidic amino acid cluster of 
CIE cargoes has already been shown to be a sufficient sorting signal for tubular 
endosome localization (5, 63), and, intriguingly, forward genetic screening by the 
gene-trap method has identified Rab10 as a candidate involved in the trafficking of the 
acidic-cluster-containing proteins (64).  Thus, it is plausible to consider the 
acidic-cluster-containing proteins good candidates for the cargoes of Rab10-positive 
tubular endosomes.  On the other hand, the in vivo role of Rab10-positive tubular 
endosomes is poorly understood, because Rab10-KO mice exhibit embryonic lethality 
(65) and specific cells or tissues containing tubular endosomes have not been identified. 
Thus, a future detailed analysis of in vivo Rab10 distribution/localization and Rab10 
conditional KO mice in various cells or tissues (66, 67) is needed.  Identification of 
acidic-cluster-containing CIE cargoes and specific cells containing Rab10-positive 
tubular endosomes will be necessary to elucidate the physiological significance of the 
formation and function of tubular endosomes. 
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FIGURE 1.  Rab8 and Rab10 are mainly localized at tubular endosomes. 
(A) Schematic representation of the method used to screen for Rabs that are mainly 
localized at tubular endosomes.  In the first step, a library of HeLaM cells stably 
expressing EGFP-Rabs (Rab1A–43) was analyzed for the presence of at least one 
EGFP-positive tubular structure >20 µm in length (blue bars in B).  In the second step, 
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EGFP-Rab-expressing HeLaM cells were immunostained with antibody against 
MICAL-L1 (a tubular endosome marker), and then PCCs for the relation between 
EGFP-Rabs and MICAL-L1 were calculated (orange bars in B). 
(B) Quantification of the results of the first step (A-1, blue bars) and the second step 
(A-2, orange bars).  The red line represents quadruple the median PCC value, and it 
was used as a threshold for tubular-endosome-localization of Rabs. 
(C) Colocalization between Rab8 (green, upper panels) and Rab10 (green, lower panels) 
and MICAL-L1 (magenta) at the endogenous protein level.  The insets are magnified 
views of the boxed areas.  Scale bars, 20 µm. 
(D) Line plot profiles of the yellow arrows in the insets in C. 
(E) Localization of EGFP-Rab10 (green), internalized Alexa594-Tf (magenta), and 
internalized anti-CD147 (cyan) in HeLaM cells.  HeLaM cells stably expressing 
EGFP-Rab10 were incubated for 2 h at 37°C with both 5 µg/ml Alexa594-Tf and 5 
µg/ml anti-CD147 antibody.  The insets are magnified views of the boxed areas.  
Scale bars, 20 µm. 
(F) Line plot profiles of the yellow arrows in the insets in E. 
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FIGURE 2.  A localization screen uncovers tubular endosome-resident Rabs. 
Localization of EGFP-Rabs (Rab5A, 8A, 10, 11A, 13, 17, 21, 22A, 23, and 35) (green) 
on tubular endosomes in HeLaM cells.  HeLaM cells stably expressing EGFP or 
EGFP-Rab (1A, 5A, 8A, 10, 11A, 13, 17, 21, 22A, 23, or 35) (green) were 
immunostained with the anti-MICAL-L1 antibody (magenta).  The insets are 
magnified views of the boxed areas.  Scale bars, 20 µm. 
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FIGURE 3.  EGFP-Rab10 is mainly localized at tubular endosomes. 
(A) Subcellular localization of EGFP-Rab10 in HeLaM cells.  HeLaM cells stably 
expressing EGFP-Rab10 (green) were immunostained with antibodies against EEA1 
85 
(EE), GM130 (cis-Golgi), TGN46 (TGN), LAMP1 (lysosome), TfR (RE), LBPA (LE), 
LC3 (autophagosome), and Rtn4 (ER) (magenta).  The insets are magnified views of 
the boxed areas.  Scale bars, 20 µm. 
(B) PCCs for the relation between EGFP-Rab10 and the organelle markers shown in A.  
The bars represent the means and SEM of data from three independent experiments (n = 
3; more than 4 images were analyzed in each experiment).  ∗,  p < 0.05; ∗∗∗,  p < 
0.001 (Dunnett’s test). 
(C) Subcellular localization of EGFP-Rab10 in DMSO- and BFA-treated HeLaM cells.  
HeLaM cells stably expressing EGFP-Rab10 (green) were treated with DMSO or 1 
µg/ml BFA for 1 h before fixation and immunostained with anti-TGN46 antibody 
(magenta).  The insets are magnified views of the boxed areas.  Scale bars, 20 µm. 
(D) PCCs for the relation between EGFP-Rab10 and TGN46 shown in C.  The bars 
represent the means and SEM of data from three independent experiments (n = 3; more 
than 4 images were analyzed in each experiment).  ∗,  p < 0.05 (unpaired two-tailed 
Student’s t test). 
(E) Percentages of cells containing at least one EGFP-Rab10-positive tubule >20 µm in 
length shown in C.  The bars represent the means and SEM of data from three 
independent experiments (n = 3; more than 20 cells were analyzed in each experiment). 
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FIGURE 4.  Rab10, not Rab8, is essential for tubular endosome formation. 
(A and B) Rab8A/B double knockout (DKO) and Rab10 knockout (KO) HeLaM cells 
generated by the CRISPR/Cas9 system.  Cell lysates of parental cells, Rab8-DKO cells, 
Rab8-DKO cells stably expressing Myc-tagged Rab8A (Rab8-DKO + Myc-Rab8A) 
cells (A), Rab10-KO cells, and Rab10-KO cells stably expressing Rab10 (Rab10-KO + 
Rab10) cells (B) were analyzed by immunoblotting with the antibodies indicated. 
(C and D) Tubular endosomes in Rab8-DKO cells (C) and Rab10-KO cells (D).  
Rab8-DKO cells and Rab8-DKO + Myc-Rab8A cells stably expressing EGFP-Rab10 
were immunostained with anti-Rab8 antibody (C).  Rab10-KO cells and Rab10-KO + 
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Rab10 cells were immunostained with antibodies against Rab8 and MICAL-L1 (D).  
The insets are magnified views of the boxed areas.  Scale bars, 20 µm. 
(E) Quantification of the percentages of cells containing at least one 
EGFP-Rab10-tubule >20 µm in length.  (F) Quantification of the percentages of cells 
containing at least one Rab8-tubule >20 µm in length.  (G) Quantification of the 
percentages of cells containing at least one MICAL-L1-tubule >20 µm in length.  The 
bars represent the means and SEM of data from three independent experiments (n = 3; 
more than 20 cells were analyzed in each experiment).  ∗∗∗, p < 0.001 (unpaired 
two-tailed Student’s t test). 
(H) Histogram analysis of the length of MICAL-L1-positive tubules in Rab10-KO cells 
and Rab10-KO + Rab10 cells.  Total tubule length (i.e., the sum of the length of all 
tubules) in individual cells was classified into five categories: “<5 µm”, “5–20 µm”, 
“20–50 µm”, “50–100 µm”, or “>100 µm”, and the number of cells containing tubules 
having the total tubule length in each category was counted as described in the 
Materials and Methods.  The numbers of cells in each category as percentages of the 
total cell population are expressed as stacked bar graphs.  The bars represent the means 
and SEM of data from three independent experiments (n = 3; more than 30 cells were 
analyzed in each experiment).  ∗∗∗, p < 0.001 (Pearson’s χ2 test). 
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FIGURE 5.  Both Rab10 and Rab22A/B are necessary for tubular endosome 
formation. 
(A) Localization of the tubular-endosome-resident Rabs (Rab5A, 8A, 11A, 13, and 
22A) in WT and Rab10-KO HeLaM cells.  WT and Rab10-KO cells stably expressing 
EGFP-Rab (Rab5A, 8A, 11A, 13, or 22A) were observed.  The insets are magnified 
views of the boxed areas.  Scale bars, 20 µm. 
(B) Rab22A/B double knockout (DKO) HeLaM cells generated by the CRISPR/Cas9 
system.  Cell lysates of parental cells, Rab22-DKO cells, and Rab22-DKO cells stably 
expressing Myc-tagged Rab22A (Rab22-DKO + Myc-Rab22A) cells were analyzed by 
immunoblotting with the antibodies indicated.  
(C) Tubular endosomes in Rab22-DKO cells.  Rab22-DKO cells and Rab22-DKO + 
Myc-Rab22A cells stably expressing EGFP-Rab10 were observed.  The insets are 
magnified views of the boxed areas.  Scale bar, 20 µm. 
(D) Percentages of cells containing at least one EGFP-Rab10-positive tubule >20 mm in 
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length shown in C.  The bars represent the means and SEM of data from three 
independent experiments (n = 3; more than 30 cells were analyzed in each experiment).  
∗∗∗, p < 0.001 (unpaired two-tailed Student’s t test). 
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FIGURE 6.  Microtubules are necessary for tubular endosome extension. 
(A) Dynamics of EGFP-Rab10-positive tubules.  HeLaM cells stably expressing 
EGFP-Rab10 were analyzed by live-cell imaging on a spinning-disk confocal 
microscope.  Image stacks of the regions of interest were captured, and maximum 
intensity projections were obtained.  The time-lapse images of the boxed area captured 
at 4.8 s intervals are shown on the right.  Arrowheads point to the fission sites of 
tubular endosomes.  Scale bars in the whole image and in the insets, 20 µm and 2 µm, 
respectively. 
(B) Effect of DMSO (control), cytochalasin D, and nocodazole on 
EGFP-Rab10-positive tubules.  HeLaM cells stably expressing EGFP-Rab10 were 
treated for 1 h with 0.1% DMSO, 10 µM cytochalasin D, or 10 µg/ml nocodazole.  
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The insets are magnified views of the boxed areas.  Scale bar, 20 µm.  ∗, p < 0.05; 
∗∗∗,  p < 0.001 (Dunnett’s test). 
(C) Percentages of cells containing EGFP-Rab10-positive tubules shown in B.  The 
bars represent the means and SEM of data from three independent experiments (n = 3; 
more than 20 cells were analyzed in each experiment). 
(D) Colocalization between EGFP-Rab10 and mStr-EMTB (a microtubule marker).  
Typical images of HeLaM cells stably co-expressing EGFP-Rab10 and mStr-EMTB 
were captured with a conventional confocal microscope (upper panels) or OSR 
(Olympus Super Resolution; lower panels).  The super-resolution images correspond 
to the boxed area in the upper left panel.  The insets in the lower panels are magnified 
views of the boxed areas.  Arrowheads point to a microtubule and EGFP-Rab10 
double-positive tubule.  Scale bars, 20 µm. 
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FIGURE 7.  KIF13A/B are novel Rab10-interacting proteins. 
(A) Schematic representation of mouse KIF13A/B.  Amino acid (AA) numbers are 
shown on both sides of each KIF13 protein. The Rab10-binding homology domain 
(named RHD10) of KIF13A/B determined in this study is represented by orange lines. 
(B) Sequence alignment and predicted secondary structure of the RBD10 or RHD10 of 
mouse KIF13A/B, EHBP1, and MICAL1.  The amino acid residues that are conserved 
and that are similar in more than three sequences are shown against a black background 
and against a shaded background, respectively.  The predicted secondary structure is 
indicated above the corresponding sequences. 
(C) A 3D-homology model of the KIF13A RHD10 and the crystal structure of the 
Rab10–MICAL1 (RBD10) complex (PDB: 5LPN).  The predicted 3D-structure of the 
KIF13A RHD10 (orange) is superimposed on the MICAL1 RBD10 (blue) in complex 
with Rab10 (silver).  The α-helix 1 and α-helix 2 in the KIF13A RHD10 of the boxed 
area correspond to the secondary structure shown in B. 
(D) Schematic representation of KIF13A/B-tail mutants without a motor domain. 
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(E) Interaction between Rab10 and KIF13A/B-tail.  mStr-Rab10 and 
EGFP-KIF13A/B-tail were co-expressed in COS-7 cells, and their associations were 
analyzed by co-immunoprecipitation assays with glutathione-Sepharose beads coupled 
with GST-GFP nanobody, followed by immunoblotting with the antibodies indicated. 
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FIGURE 8.  The RHD10 of KIF13 is required for its localization at 
EGFP-Rab10-positive tubules. 
(A) Localization of Myc-KIF13A (WT and ΔRHD10).  HeLaM cells stably 
co-expressing EGFP-Rab10 (green) and Myc-KIF13A (WT or ΔRHD10; magenta) 
were examined.  The insets are magnified views of the boxed areas.  Scale bars, 20 
µm. 
(B) Line plot profiles of the yellow arrows in the insets in A. 
(C) Schematic representation of a KIF13A(ΔRHD10) mutant that lacks an RHD10 
shown in orange. 
(D) PCCs for the relation between EGFP-Rab10 and Myc-KIF13A (WT or ΔRHD10) 
shown in A.  The bars represent the means and SEM of data from three independent 
experiments (n = 3; more than 5 images were analyzed in each experiment).  ∗,  p < 
0.05 (unpaired two-tailed Student’s t test). 
(E) Localization of Myc-KIF13A in Rab10-KO cells.  Rab10-KO cells stably 
expressing Myc-KIF13A (green) were immunostained with the anti-MICAL-L1 
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antibody.  The insets are magnified views of the boxed areas.  Scale bars, 20 µm. 
(F) Percentages of cells containing at least one Myc-KIF13A-positive tubule >20 µm in 
length shown in E.  The bars represent the means and SEM of data from three 
independent experiments (n = 3; more than 20 cells were analyzed in each experiment).  
∗,  p < 0.05 (unpaired two-tailed Student’s t test). 
(G) Unaltered expression of KIF13A/B in Rab10-KO cells.  Cell lysates of parental 
(WT) cells, Rab10-KO cells, and Rab10-KO cells stably expressing Rab10 (Rab10-KO 
+ Rab10) were analyzed by immunoblotting with the antibodies indicated. 
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FIGURE 9.  The RHD10 of KIF13B is required for its localization at 
EGFP-Rab10-positive tubules. 
(A) Schematic representation of KIF13B-tail (WT and ΔRHD10) mutants. 
(B) Localization of EGFP-KIF13B-tail (WT and ΔRHD10).  HeLaM cells transiently 
co-expressing EGFP-KIF13B-tail (WT or ΔRHD10; green) and mStr-Rab10 (magenta) 
were observed.  The insets are magnified views of the boxed areas.  Scale bars, 20 
µm. 
97 
 
FIGURE 10.  Both the motor domain and the RHD10 of KIF13A are necessary 
for tubular endosome formation. 
(A) KIF13A-KO, KIF13B-KO, and KIF13-DKO HeLaM cells generated by the 
CRISPR/Cas9 system.  Cell lysates of parental (WT), KIF13A-KO, KIF13B-KO, and 
KIF13-DKO cells were analyzed by immunoblotting with the antibodies indicated. 
(B) Tubular endosomes in KIF13A-KO, KIF13B-KO, and KIF13-DKO cells.  Each 
cell line was immunostained with the anti-MICAL-L1 antibody.  The insets are 
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magnified views of the boxed areas.  Scale bar, 20 µm. 
(C) Percentages of cells containing at least one MICAL-L1-positive tubule >20 µm in 
length shown in B.  ∗∗, p < 0.01; ∗∗∗,  p < 0.001 (Dunnett’s test). 
(D) Rescue of KIF13A-KO cells by exogenous expression of KIF13A mutants.  
KIF13A-KO cells stably co-expressing EGFP-Rab10 (green) and Myc-KIF13A (WT, 
ΔRHD10, or tail) (magenta) were tested.  The insets are magnified views of the boxed 
areas.  Scale bars, 20 µm. 
(E) Similar level of Myc-KIF13A expression (WT, ΔRHD10, or tail) in KIF13A-KO 
cells.  Cell lysates of parental (WT) cells, KIF13A-KO cells, and KIF13A-KO cells 
stably expressing Myc-KIF13A (WT, ΔRHD10, or tail) were analyzed by 
immunoblotting with the antibodies indicated. 
(F) Percentages of cells containing at least one EGFP-Rab-10-positive tubule >20 µm in 
length shown in D.  The bars represent the means and SEM of data from three 
independent experiments (n = 3; more than 20 cells were analyzed in each experiment).  
∗∗∗, p < 0.001 (one-way analysis of variance followed by the Tukey-Kramer test). 
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FIGURE 11.  Overexpression of HA-KIF13A/B rescued the disruption of tubular 
endosomes in KIF13A-KO cells. 
Tubular endosomes in KIF13A-KO cells transiently expressing HA-KIF13A or 
HA-KIF13B.  The cells were immunostained with antibodies against Rab8 (green) and 
MICAL-L1 (magenta).  The insets are magnified views of the boxed areas.  Box 1 
(yellow) and Box 2 (white) indicate the cells expressing HA-KIF13 and not expressing 
HA-KIF13, respectively.  Scale bars, 20 µm. 
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FIGURE 12.  Proposed model of the role of Rabs in tubular endosome formation. 
(A) In HeLaM cells, Rab10 is localized at endosomes and recruits KIF13 motors to 
induce endosome tubulation by pulling along a microtubule track. 
(B) Proposed model of Rab-mediated tubular endosome formation based on the results 
obtained in the present study together with previous reports (see Discussions for details).  
In the first step, CIE cargoes, including CD147, are internalized through the 
Arf6-dependent pathway (9), and Rab13 and 35 may be involved in this step through 
actin reorganization (57, 58).  In the second step, the internalized vesicle-to-tubular 
endosome transition occurs (55).  Rab10 and 22A/B are necessary to complete this 
step, and thus KO of either Rab10 or 22A/B caused failure of tubular endosomes to 
develop. Rab5A and 21, neither of which colocalized with MICAL-L1, may not be 
directly involved in CIE cargo sorting/transport (4, 63).  In the final step, the CIE 
cargoes in the tubular endosome are sorted and transported into the PM, RE, or TGN 
(Step 3) (4, 8).  Rab8, 11A, and 17 may contribute to this step (15, 42, 61). 
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